The	O
c-Jun	B-protein
delta-domain	I-protein
inhibits	O
neuroendocrine	B-DNA
promoter	I-DNA
activity	O
in	O
a	O
DNA	O
sequence-	O
and	O
pituitary-specific	O
manner	O
.	O

The	O
transcription	O
and	O
transformation	O
activity	O
of	O
c-Jun	B-protein
is	O
governed	O
by	O
a	O
27-amino	B-protein
acid	I-protein
regulatory	I-protein
motif	I-protein
,	O
labeled	O
the	O
delta-domain	B-protein
,	O
which	O
is	O
deleted	O
in	O
v-Jun	B-protein
.	O

We	O
have	O
previously	O
shown	O
that	O
c-Jun	B-protein
is	O
a	O
potent	O
inhibitor	O
of	O
the	O
rat	B-DNA
prolactin	I-DNA
(	I-DNA
rPRL	I-DNA
)	I-DNA
promoter	I-DNA
activity	O
induced	O
by	O
either	O
oncogenic	B-protein
Ras	I-protein
or	O
phorbol	O
esters	O
.	O

Here	O
,	O
we	O
have	O
characterized	O
the	O
structural	O
and	O
cell-specific	O
requirements	O
for	O
this	O
c-Jun	B-protein
inhibitory	O
response	O
,	O
and	O
we	O
show	O
that	O
this	O
c-Jun	B-protein
inhibitory	O
response	O
mapped	O
to	O
the	O
rPRL	B-DNA
footprint	I-DNA
II	I-DNA
repressor	I-DNA
site	I-DNA
,	O
was	O
pituitary-specific	O
and	O
required	O
the	O
c-Jun	B-protein
delta-domain	I-protein
.	O

Moreover	O
,	O
alteration	O
of	O
any	O
one	O
of	O
these	O
features	O
(	O
e.g.	O
,	O
cis-element	B-DNA
,	O
trans-factor	B-DNA
,	O
or	O
cell-specific	O
background	O
)	O
switched	O
c-Jun	B-protein
to	O
a	O
transcriptional	B-protein
activator	I-protein
of	O
the	O
rPRL	B-DNA
promoter	I-DNA
.	O

In	O
HeLa	B-cell_line
nonpituitary	I-cell_line
cells	I-cell_line
,	O
c-Jun	B-protein
alone	O
activated	O
the	O
rPRL	B-DNA
promoter	I-DNA
via	O
the	O
most	O
proximal	O
GHF-1/Pit-1	B-DNA
binding	I-DNA
site	I-DNA
,	O
footprint	B-DNA
I	I-DNA
,	O
and	O
synergized	O
with	O
GHF-1	B-protein
.	O

Finally	O
,	O
recombinant	O
GHF-1	B-protein
interacted	O
directly	O
with	O
c-Jun	B-protein
but	O
not	O
c-Fos	B-protein
proteins	I-protein
.	O

These	O
data	O
provide	O
important	O
fundamental	O
insights	O
into	O
the	O
molecular	O
mechanisms	O
by	O
which	O
the	O
c-Jun	B-protein
delta-domain	I-protein
functions	O
as	O
a	O
modulatory	O
switch	O
and	O
further	O
imply	O
that	O
the	O
functional	O
role	O
of	O
c-Jun	B-protein
is	O
dictated	O
by	O
cell-specific	O
influences	O
and	O
the	O
delta-domain	B-protein
motif	I-protein
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

29	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
19	NULL
,	NULL
pp	NULL
.	NULL

17139-17146	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

The	NULL
c-Jun	NULL
6-Domain	NULL
Inhibits	NULL
Neuroendocrine	NULL
Promoter	NULL
Activity	NULL
in	NULL
a	NULL
DNA	NULL
Sequence-	NULL
and	NULL
Pituitary-specific	NULL
Manner*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
March	NULL
25	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
2	NULL
,	NULL
1996	NULL
)	NULL
Kathryn	NULL
N.	NULL
Farrow	NULL
,	NULL
Nicole	NULL
Manning	NULL
,	NULL
Fred	NULL
Schaufele	NULL
?	NULL

,	NULL
and	NULL
Arthur	NULL
Gutierrez-Hartmann§	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Biophysics	NULL
and	NULL
Genetics	NULL
,	NULL
the	NULL
Program	NULL
in	NULL
Molecular	NULL
Biology	NULL
,	NULL
and	NULL
the	NULL
Colorado	NULL
Cancer	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
and	NULL
the	NULL
{	NULL
Metabolic	NULL
Research	NULL
Unit	NULL
HSW-1143	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
94143-0962	NULL
The	NULL
transcription	NULL
and	NULL
transformation	NULL
activity	NULL
of	NULL
cJun	NULL
is	NULL
governed	NULL
by	NULL
a	NULL
27-amino	NULL
acid	NULL
regulatory	NULL
motif	NULL
,	NULL
labeled	NULL
the	NULL
6-domain	NULL
,	NULL
which	NULL
is	NULL
deleted	NULL
in	NULL
v-Jun	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
c-Jun	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
the	NULL
rat	NULL
prolactin	NULL
(	NULL
rPRL	NULL
)	NULL
promoter	NULL
activity	NULL
induced	NULL
by	NULL
either	NULL
oncogenic	NULL
Ras	NULL
or	NULL
phorbol	NULL
esters	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
structural	NULL
and	NULL
cell-specific	NULL
requirements	NULL
for	NULL
this	NULL
c-Jun	NULL
inhibitory	NULL
response	NULL
,	NULL
and	NULL
we	NULL
show	NULL
that	NULL
this	NULL
c-Jun	NULL
inhibitory	NULL
response	NULL
mapped	NULL
to	NULL
the	NULL
rPRL	NULL
footprint	NULL
II	NULL
repressor	NULL
site	NULL
,	NULL
was	NULL
pituitary-specific	NULL
and	NULL
required	NULL
the	NULL
c-Jun	NULL
a-domain	NULL
.	NULL

Moreover	NULL
,	NULL
alteration	NULL
of	NULL
any	NULL
one	NULL
of	NULL
these	NULL
features	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
cis-element	NULL
,	NULL
trans-factor	NULL
,	NULL
or	NULL
cell-specific	NULL
background	NULL
)	NULL
switched	NULL
c-Jun	NULL
to	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

In	NULL
Hela	NULL
nonpituitary	NULL
cells	NULL
,	NULL
c-Jun	NULL
alone	NULL
activated	NULL
the	NULL
rPRL	NULL
promoter	NULL
via	NULL
the	NULL
most	NULL
proximal	NULL
GHF-1/Pit-1	NULL
binding	NULL
site	NULL
,	NULL
footprint	NULL
I	NULL
,	NULL
and	NULL
synergized	NULL
with	NULL
GHEF-1	NULL
.	NULL

Finally	NULL
,	NULL
recombinant	NULL
GHF-1	NULL
interacted	NULL
directly	NULL
with	NULL
c-Jun	NULL
but	NULL
not	NULL
c-Fos	NULL
proteins	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
important	NULL
fundamental	NULL
insights	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
c-Jun	NULL
6-domain	NULL
functions	NULL
as	NULL
a	NULL
modulatory	NULL
switch	NULL
and	NULL
further	NULL
imply	NULL
that	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
c-Jun	NULL
is	NULL
dictated	NULL
by	NULL
cell-specific	NULL
influences	NULL
and	NULL
the	NULL
6-domain	NULL
motif	NULL
.	NULL

c-Jun	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
BZip	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
are	NULL
characterized	NULL
by	NULL
a	NULL
basic	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
a	NULL
leucine	NULL
zipper	NULL
protein	NULL
dimerization	NULL
domain	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

cjun	NULL
was	NULL
first	NULL
described	NULL
as	NULL
the	NULL
cellular	NULL
homologue	NULL
of	NULL
the	NULL
v-Jun	NULL
oncogene	NULL
,	NULL
and	NULL
subsequently	NULL
,	NULL
many	NULL
other	NULL
BZip	NULL
family	NULL
members	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
including	NULL
several	NULL
Jun-like	NULL
and	NULL
Fos-like	NULL
proteins	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

c-Jun	NULL
and	NULL
c-Fos	NULL
can	NULL
combine	NULL
to	NULL
form	NULL
homo-	NULL
and	NULL
het-erodimers	NULL
,	NULL
with	NULL
Jun-Jun	NULL
homodimers	NULL
and	NULL
Jun-Fos	NULL
het-erodimers	NULL
(	NULL
also	NULL
referred	NULL
to	NULL
as	NULL
an	NULL
AP-1	NULL
complex	NULL
)	NULL
,	NULL
binding	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
the	NULL
consensus	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
TGACTCA	NULL
,	NULL
whereas	NULL
Fos-Fos	NULL
homodimers	NULL
are	NULL
unable	NULL
to	NULL
stably	NULL
bind	NULL
to	NULL
this	NULL
sequence	NULL
(	NULL
1	NULL
,	NULL
6-8	NULL
)	NULL
.	NULL

Once	NULL
bound	NULL
to	NULL
DNA	NULL
,	NULL
their	NULL
effects	NULL
are	NULL
mediated	NULL
through	NULL
amino-terminal	NULL
transactivation	NULL
domains	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
cell	NULL
,	NULL
c-Jun	NULL
serves	NULL
as	NULL
a	NULL
downstream	NULL
target	NULL
for	NULL
several	NULL
signaling	NULL
pathways	NULL
,	NULL
including	NULL
12-O-tetradecanoyl	NULL
phorbol	NULL
13-ac-etate	NULL
(	NULL
TPA	NULL
)	NULL
,	NULL
``	NULL
a	NULL
phorbol	NULL
ester	NULL
that	NULL
activates	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
8	NULL
,	NULL
*	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
Grant	NULL
BE-199	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
4200	NULL
E.	NULL
Ninth	NULL
Ave.	NULL
,	NULL
Box	NULL
B-151	NULL
,	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80262	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
303-270-8443	NULL
;	NULL
Fax	NULL
:	NULL
303-270-4525	NULL
;	NULL
E-mail	NULL
:	NULL
a.gutierrez-hartmann	NULL
@	NULL
UCHSC.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TPA	NULL
,	NULL
12-O-tetradecanoyl	NULL
phorbol	NULL
13-acetate	NULL
;	NULL
GH	NULL
,	NULL
growth	NULL
hormone	NULL
;	NULL
rGH	NULL
,	NULL
rat	NULL
GH	NULL
;	NULL
PRL	NULL
,	NULL
prolactin	NULL
;	NULL
rPRL	NULL
,	NULL
rat	NULL
PRL	NULL
;	NULL
FP	NULL
,	NULL
footprint	NULL
;	NULL
RSV	NULL
,	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
;	NULL
TK	NULL
,	NULL
thymidine	NULL
kinase	NULL
;	NULL
JNK	NULL
,	NULL
Jun	NULL
kinase	NULL
.	NULL

10	NULL
)	NULL
and	NULL
oncogenic	NULL
Ha-Ras	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

TPA	NULL
mediates	NULL
its	NULL
transcriptional	NULL
effects	NULL
through	NULL
a	NULL
TPA-responsive	NULL
element	NULL
,	NULL
which	NULL
is	NULL
equivalent	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
noted	NULL
above	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
Ha-Ras	NULL
leads	NULL
to	NULL
activation	NULL
of	NULL
Jun	NULL
kinase	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
amino-terminal	NULL
serines	NULL
63	NULL
and	NULL
73	NULL
in	NULL
the	NULL
transcription	NULL
activation	NULL
domain	NULL
of	NULL
c-Jun	NULL
,	NULL
thereby	NULL
enhancing	NULL
its	NULL
transcription	NULL
potency	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Also	NULL
present	NULL
in	NULL
the	NULL
amino	NULL
terminus	NULL
of	NULL
c-Jun	NULL
,	NULL
but	NULL
deleted	NULL
in	NULL
v-Jun	NULL
,	NULL
is	NULL
a	NULL
region	NULL
known	NULL
as	NULL
the	NULL
8-domain	NULL
(	NULL
19	NULL
)	NULL
.	NULL

This	NULL
27-amino	NULL
acid	NULL
region	NULL
is	NULL
important	NULL
for	NULL
cell-specific	NULL
modulatory	NULL
effects	NULL
on	NULL
transcription	NULL
and	NULL
transformation	NULL
potency	NULL
of	NULL
c-Jun	NULL
versus	NULL
v-Jun	NULL
,	NULL
thought	NULL
to	NULL
be	NULL
mediated	NULL
via	NULL
protein-protein	NULL
interactions	NULL
(	NULL
9	NULL
,	NULL
20-23	NULL
)	NULL
.	NULL

One	NULL
such	NULL
8-domain-specific	NULL
interaction	NULL
is	NULL
with	NULL
Jun	NULL
kinase	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
amino-terminal	NULL
half	NULL
of	NULL
the	NULL
8-domain	NULL
spanning	NULL
amino	NULL
acids	NULL
34-45	NULL
and	NULL
phosphorylates	NULL
c-Jun	NULL
but	NULL
not	NULL
v-Jun	NULL
(	NULL
9	NULL
,	NULL
18	NULL
,	NULL
24-26	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
although	NULL
c-Jun	NULL
typically	NULL
activates	NULL
gene	NULL
tran-scription	NULL
,	NULL
examples	NULL
have	NULL
accumulated	NULL
documenting	NULL
that	NULL
it	NULL
can	NULL
also	NULL
inhibit	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
direct	NULL
mode	NULL
of	NULL
inhibitory	NULL
action	NULL
was	NULL
shown	NULL
in	NULL
the	NULL
c-fos	NULL
gene	NULL
,	NULL
where	NULL
the	NULL
AP-1	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
c-fos	NULL
promoter	NULL
to	NULL
down-regulate	NULL
c-fos	NULL
gene	NULL
expression	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
AP-1	NULL
complex	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
TPA-responsive	NULL
element	NULL
that	NULL
overlaps	NULL
a	NULL
critical	NULL
retinoic	NULL
acid	NULL
response	NULL
element/vitamin	NULL
D	NULL
response	NULL
element	NULL
required	NULL
for	NULL
os-teocalcin	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
thus	NULL
sterically	NULL
interferes	NULL
with	NULL
retinoic	NULL
acid	NULL
receptor/vitamin	NULL
D	NULL
receptor	NULL
binding	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
certain	NULL
cases	NULL
,	NULL
c-Jun	NULL
heterodimerizes	NULL
with	NULL
other	NULL
activators	NULL
,	NULL
either	NULL
via	NULL
its	NULL
leucine	NULL
zipper	NULL
motif	NULL
,	NULL
e.g	NULL
.	NULL

with	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
(	NULL
29	NULL
)	NULL
,	NULL
or	NULL
via	NULL
its	NULL
amino-terminal	NULL
domain	NULL
,	NULL
e.g	NULL
.	NULL

with	NULL
MyoD	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
c-Jun	NULL
to	NULL
inhibit	NULL
the	NULL
muscle-specific	NULL
crea-tine	NULL
kinase	NULL
gene	NULL
(	NULL
30	NULL
)	NULL
,	NULL
cardiac-specific	NULL
atrial	NULL
natriuretic	NULL
factor	NULL
gene	NULL
(	NULL
31	NULL
)	NULL
,	NULL
or	NULL
the	NULL
liver-specific	NULL
a-fetoprotein	NULL
gene	NULL
(	NULL
82	NULL
)	NULL
was	NULL
mapped	NULL
to	NULL
the	NULL
amino-terminal	NULL
domain	NULL
of	NULL
c-Jun	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
it	NULL
is	NULL
striking	NULL
that	NULL
in	NULL
each	NULL
case	NULL
whereby	NULL
c-Jun	NULL
inhibits	NULL
a	NULL
highly	NULL
specialized	NULL
,	NULL
tissue-specific	NULL
gene	NULL
,	NULL
it	NULL
does	NULL
so	NULL
via	NULL
its	NULL
amino-terminal	NULL
domain	NULL
,	NULL
usually	NULL
requiring	NULL
just	NULL
the	NULL
first	NULL
87	NULL
amino	NULL
acids	NULL
,	NULL
including	NULL
the	NULL
8-domain	NULL
.	NULL

One	NULL
of	NULL
the	NULL
first	NULL
indications	NULL
that	NULL
the	NULL
8-domain	NULL
serves	NULL
a	NULL
regulatory	NULL
function	NULL
was	NULL
noted	NULL
in	NULL
cell-free	NULL
transcription	NULL
studies	NULL
.	NULL

Recombinant	NULL
c-Jun	NULL
proteins	NULL
containing	NULL
the	NULL
8-domain	NULL
weakly	NULL
activated	NULL
an	NULL
AP-1-driven	NULL
promoter	NULL
in	NULL
Jun/Fos-depleted	NULL
Hela	NULL
cell	NULL
extracts	NULL
,	NULL
whereas	NULL
v-Jun	NULL
or	NULL
amino-terminal	NULL
truncated	NULL
c-Jun	NULL
proteins	NULL
,	NULL
devoid	NULL
of	NULL
the	NULL
8-domain	NULL
,	NULL
were	NULL
very	NULL
active	NULL
in	NULL
this	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
all	NULL
of	NULL
these	NULL
recombinant	NULL
Jun	NULL
proteins	NULL
bound	NULL
equally	NULL
well	NULL
to	NULL
the	NULL
TPA-responsive	NULL
DNA	NULL
element	NULL
.	NULL

Using	NULL
in	NULL
vivo	NULL
gene	NULL
transfer	NULL
methods	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
a	NULL
c-Jun	NULL
fusion	NULL
protein	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
E2	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
from	NULL
bovine	NULL
papilloma	NULL
virus	NULL
,	NULL
activated	NULL
the	NULL
appropriate	NULL
promoter-reporter	NULL
plasmid	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
8-domain	NULL
resulted	NULL
in	NULL
an	NULL
enhancement	NULL
of	NULL
Jun	NULL
's	NULL
activation	NULL
effect	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
not	NULL
all	NULL
tested	NULL
cells	NULL
revealed	NULL
this	NULL
differential	NULL
effect	NULL
of	NULL
c-Jun	NULL
versus	NULL
v-Jun	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
c-Jun	NULL
171839	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
17140	NULL
and	NULL
v-Jun	NULL
were	NULL
the	NULL
same	NULL
in	NULL
REF	NULL
,	NULL
SL2	NULL
,	NULL
and	NULL
F9	NULL
cells	NULL
,	NULL
whereas	NULL
c-Jun	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
better	NULL
transactivator	NULL
than	NULL
v-Jun	NULL
in	NULL
CEF	NULL
and	NULL
HepG2	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
20	NULL
,	NULL
22	NULL
)	NULL
.	NULL

While	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
8-domain	NULL
operates	NULL
as	NULL
a	NULL
critical	NULL
negative	NULL
regulatory	NULL
domain	NULL
stems	NULL
from	NULL
the	NULL
observation	NULL
that	NULL
simply	NULL
removing	NULL
the	NULL
3-domain	NULL
from	NULL
c-Jun	NULL
results	NULL
in	NULL
its	NULL
oncogenic	NULL
activation	NULL
,	NULL
it	NULL
has	NULL
become	NULL
increasingly	NULL
clear	NULL
that	NULL
transformation	NULL
and	NULL
transcription	NULL
potency	NULL
of	NULL
Jun	NULL
proteins	NULL
are	NULL
not	NULL
directly	NULL
correlated	NULL
and	NULL
may	NULL
even	NULL
be	NULL
inversely	NULL
related	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Despite	NULL
this	NULL
important	NULL
progress	NULL
in	NULL
elucidating	NULL
the	NULL
structural	NULL
features	NULL
of	NULL
Jun	NULL
proteins	NULL
,	NULL
the	NULL
precise	NULL
rules	NULL
by	NULL
which	NULL
the	NULL
8-domain	NULL
functions	NULL
remain	NULL
unknown	NULL
.	NULL

The	NULL
prolactin	NULL
and	NULL
growth	NULL
hormone	NULL
(	NULL
GH	NULL
)	NULL
genes	NULL
are	NULL
two	NULL
an-cestrally	NULL
related	NULL
genes	NULL
whose	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
lactotroph	NULL
and	NULL
somatotroph	NULL
cells	NULL
of	NULL
the	NULL
anterior	NULL
pituitary	NULL
,	NULL
respectively	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
ontogeny	NULL
of	NULL
these	NULL
pituitary	NULL
cells	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
pituitary-specific	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
POU	NULL
homeodomain	NULL
transcription	NULL
factor	NULL
,	NULL
GHF-1/Pit-1	NULL
(	NULL
33	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Significant	NULL
insights	NULL
into	NULL
basal	NULL
and	NULL
hor-mone-activated	NULL
PRL	NULL
and	NULL
GH	NULL
gene	NULL
expression	NULL
have	NULL
been	NULL
provided	NULL
by	NULL
GH	NULL
,	NULL
rat	NULL
pituitary	NULL
tumor	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
a	NULL
clonal	NULL
cell	NULL
line	NULL
that	NULL
maintains	NULL
cell	NULL
type-specific	NULL
functions	NULL
and	NULL
hormonal	NULL
responses	NULL
(	NULL
33	NULL
,	NULL
34	NULL
,	NULL
37-39	NULL
)	NULL
.	NULL

Previous	NULL
experiments	NULL
in	NULL
this	NULL
system	NULL
have	NULL
demonstrated	NULL
that	NULL
c-Jun	NULL
does	NULL
not	NULL
function	NULL
as	NULL
a	NULL
downstream	NULL
target	NULL
for	NULL
either	NULL
oncogenic	NULL
V12	NULL
Ras-	NULL
or	NULL
TPA-mediated	NULL
activation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
,	NULL
but	NULL
instead	NULL
c-Jun	NULL
inhibits	NULL
both	NULL
of	NULL
these	NULL
signal	NULL
transduction	NULL
pathways	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Yet	NULL
this	NULL
inhibitory	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
V12	NULL
Ras-	NULL
and	NULL
TPA-mediated	NULL
activation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
is	NULL
promoter-specific	NULL
and	NULL
not	NULL
GH	NULL
,	NULL
cell-specific	NULL
,	NULL
since	NULL
we	NULL
demonstrated	NULL
that	NULL
c-Jun	NULL
enhances	NULL
V12	NULL
Ras	NULL
stimulation	NULL
of	NULL
the	NULL
AP-1-dependent	NULL
-73ColCAT	NULL
promoter-reporter	NULL
construct	NULL
(	NULL
40	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
c-Jun	NULL
is	NULL
capable	NULL
of	NULL
serving	NULL
multiple	NULL
functions	NULL
within	NULL
these	NULL
cells	NULL
and	NULL
that	NULL
some	NULL
of	NULL
these	NULL
functions	NULL
are	NULL
promoter-specific	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
rPRL	NULL
promoter	NULL
and	NULL
GH	NULL
,	NULL
pituitary	NULL
cells	NULL
provide	NULL
an	NULL
important	NULL
model	NULL
system	NULL
in	NULL
which	NULL
to	NULL
elucidate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
c-Jun	NULL
mediates	NULL
promoter-	NULL
and	NULL
cell-specific	NULL
effects	NULL
.	NULL

The	NULL
goal	NULL
of	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
was	NULL
to	NULL
dissect	NULL
the	NULL
mechanism	NULL
of	NULL
c-Jun	NULL
inhibition	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
GH	NULL
,	NULL
neuroendocrine	NULL
cells	NULL
.	NULL

Using	NULL
transient	NULL
transfection	NULL
studies	NULL
we	NULL
showed	NULL
that	NULL
c-Jun	NULL
selectively	NULL
inhibits	NULL
basal	NULL
rPRL	NULL
promoter	NULL
via	NULL
the	NULL
amino-terminal	NULL
c-Jun	NULL
8-domain	NULL
and	NULL
that	NULL
this	NULL
inhibition	NULL
required	NULL
the	NULL
rPRL	NULL
promoter	NULL
FP	NULL
II	NULL
repressor-binding	NULL
site	NULL
and	NULL
pituitary-specific	NULL
influences	NULL
.	NULL

Moreover	NULL
,	NULL
eliminating	NULL
any	NULL
one	NULL
of	NULL
these	NULL
elements	NULL
switched	NULL
Jun	NULL
function	NULL
on	NULL
the	NULL
rPRL	NULL
promoter	NULL
to	NULL
an	NULL
activator	NULL
.	NULL

These	NULL
data	NULL
provide	NULL
critical	NULL
and	NULL
novel	NULL
insights	NULL
into	NULL
the	NULL
regulatory	NULL
functions	NULL
of	NULL
the	NULL
c-Jun	NULL
8-domain	NULL
and	NULL
further	NULL
imply	NULL
that	NULL
the	NULL
precise	NULL
functional	NULL
role	NULL
of	NULL
c-Jun	NULL
is	NULL
dictated	NULL
by	NULL
the	NULL
potential	NULL
interaction	NULL
of	NULL
cell-specific	NULL
factors	NULL
with	NULL
the	NULL
8-domain	NULL
motif	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Plasmid	NULL
Constructs-The	NULL
pituitary	NULL
promoter-luciferase	NULL
constructs	NULL
,	NULL
pA	NULL
,	NULL
PRLluc-425	NULL
,	NULL
pA	NULL
,	NULL
rGHlue	NULL
,	NULL
and	NULL
pA	NULL
,	NULL
halue-1760	NULL
have	NULL
been	NULL
described	NULL
(	NULL
39	NULL
,	NULL
42	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
-255	NULL
,	NULL
-189	NULL
,	NULL
-125	NULL
,	NULL
-54	NULL
,	NULL
and	NULL
-36	NULL
rPRL	NULL
promoter	NULL
deletions	NULL
were	NULL
prepared	NULL
in	NULL
pGT7PRL	NULL
by	NULL
5°	NULL
exonuclease	NULL
digestion	NULL
,	NULL
sub-cloned	NULL
into	NULL
SaZl/HindlIII-cut	NULL
pA	NULL
;	NULL
lue	NULL
,	NULL
and	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
,	NULL
and	NULL
they	NULL
will	NULL
be	NULL
described	NULL
in	NULL
detail	NULL
elsewhere	NULL
.	NULL
``	NULL

The	NULL
site-specific	NULL
mutants	NULL
in	NULL
FP	NULL
I	NULL
(	NULL
pA	NULL
,	NULL
Allue	NULL
)	NULL
,	NULL
FP	NULL
II	NULL
(	NULL
pA	NULL
,	NULL
A2luc	NULL
)	NULL
,	NULL
and	NULL
FP	NULL
II	NULL
together	NULL
with	NULL
a	NULL
loop-out	NULL
deletion	NULL
of	NULL
the	NULL
-112	NULL
to	NULL
-80	NULL
basal	NULL
transcription	NULL
element	NULL
(	NULL
BTE	NULL
)	NULL
region	NULL
(	NULL
pA	NULL
,	NULL
A2	NULL
,	NULL
Dluc	NULL
)	NULL
were	NULL
constructed	NULL
in	NULL
the	NULL
-425	NULL
to	NULL
+78	NULL
rPRL	NULL
promoter	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
89	NULL
,	NULL
43	NULL
)	NULL
.	NULL

The	NULL
FP	NULL
IFP	NULL
III	NULL
double	NULL
mutant	NULL
(	NULL
pA	NULL
,	NULL
A1	NULL
,	NULL
S3lue	NULL
)	NULL
was	NULL
constructed	NULL
in	NULL
the	NULL
-425	NULL
to	NULL
+73	NULL
rPRL	NULL
promoter	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Plasmids	NULL
pRSVc-jun	NULL
,	NULL
pRSVv-jun	NULL
,	NULL
and	NULL
pRS-VGHF-1	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Karin	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
8	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pRSV	NULL
B-globin	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Drs	NULL
.	NULL

Tim	NULL
Reudelhuber	NULL
and	NULL
John	NULL
D.	NULL
Baxter	NULL
(	NULL
University	NULL
of	NULL
*	NULL
A.	NULL
P.	NULL
Bradford	NULL
,	NULL
K.	NULL
E.	NULL
Conrad	NULL
,	NULL
P.	NULL
Tran	NULL
,	NULL
M.	NULL
C.	NULL
Ostrowski	NULL
,	NULL
and	NULL
A.	NULL
Gutierrez-Hartmann	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pe-fosTKluc	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
c-fos	NULL
enhancer	NULL
spanning	NULL
-857	NULL
to	NULL
-276	NULL
fused	NULL
to	NULL
the	NULL
TK	NULL
promoter	NULL
-200	NULL
to	NULL
+70	NULL
and	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pCMVlue	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Mike	NULL
Smith	NULL
(	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

Plasmids	NULL
pRSV-lue400	NULL
and	NULL
pA	NULL
,	NULL
SV4O0luec	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
45	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Plasmids	NULL
pGem4	NULL
and	NULL
pGem7	NULL
were	NULL
both	NULL
obtained	NULL
from	NULL
Promega	NULL
Corp.	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Plasmid	NULL
DNAs	NULL
were	NULL
purified	NULL
either	NULL
by	NULL
alkaline-SDS	NULL
extraction	NULL
followed	NULL
by	NULL
cesium	NULL
chloride	NULL
density	NULL
gradient	NULL
centrifugation	NULL
(	NULL
50	NULL
)	NULL
or	NULL
according	NULL
to	NULL
the	NULL
Qiagen	NULL
Mega	NULL
protocol	NULL
(	NULL
Qiagen	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Plasmids	NULL
were	NULL
quantitated	NULL
by	NULL
both	NULL
absorbance	NULL
at	NULL
260	NULL
nm	NULL
and	NULL
by	NULL
comparison	NULL
with	NULL
DNA	NULL
standards	NULL
on	NULL
agarose	NULL
electrophoresis	NULL
(	NULL
50	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
observed	NULL
in	NULL
transfection	NULL
results	NULL
using	NULL
plasmids	NULL
prepared	NULL
by	NULL
the	NULL
two	NULL
different	NULL
purification	NULL
methods	NULL
.	NULL

Cell	NULL
Culture	NULL
,	NULL
Electroporation	NULL
,	NULL
and	NULL
Luciferase	NULL
Assay-GH	NULL
,	NULL
T2	NULL
rat	NULL
pituitary	NULL
tumor	NULL
cells	NULL
and	NULL
Hela	NULL
human	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
50	NULL
ug/ml	NULL
of	NULL
penicillin	NULL
and	NULL
streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
via	NULL
electroporation	NULL
,	NULL
keeping	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
constant	NULL
with	NULL
pGEMT7	NULL
or	NULL
pGEM4	NULL
DNA	NULL
,	NULL
and	NULL
pRSV	NULL
-globin	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
nonspecific	NULL
effects	NULL
of	NULL
RSV	NULL
expression	NULL
vectors	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Electroporations	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
for	NULL
each	NULL
condition	NULL
within	NULL
a	NULL
single	NULL
experiment	NULL
,	NULL
and	NULL
experiments	NULL
were	NULL
repeated	NULL
using	NULL
different	NULL
plasmid	NULL
preparations	NULL
of	NULL
each	NULL
construct	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
unless	NULL
otherwise	NULL
stated	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
87	NULL
)	NULL
.	NULL

Luciferase	NULL
light	NULL
units	NULL
of	NULL
the	NULL
control	NULL
value	NULL
were	NULL
set	NULL
to	NULL
1	NULL
,	NULL
and	NULL
the	NULL
data	NULL
was	NULL
expressed	NULL
as	NULL
-fold	NULL
stimulation	NULL
relative	NULL
to	NULL
control	NULL
.	NULL

All	NULL
data	NULL
was	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

for	NULL
replicated	NULL
experiments	NULL
.	NULL

Since	NULL
c-Jun	NULL
expression	NULL
modulated	NULL
the	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
various	NULL
viral	NULL
promoters	NULL
typically	NULL
used	NULL
to	NULL
drive	NULL
a	NULL
B-galactosidase	NULL
reporter	NULL
,	NULL
those	NULL
B-galactosidase	NULL
vectors	NULL
could	NULL
not	NULL
be	NULL
used	NULL
as	NULL
internal	NULL
controls	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
by	NULL
repeating	NULL
the	NULL
various	NULL
transfections	NULL
multiple	NULL
times	NULL
and	NULL
applying	NULL
statistical	NULL
analysis	NULL
to	NULL
the	NULL
resultant	NULL
data	NULL
,	NULL
we	NULL
are	NULL
able	NULL
to	NULL
achieve	NULL
consistency	NULL
of	NULL
agreement	NULL
that	NULL
is	NULL
equal	NULL
to	NULL
or	NULL
better	NULL
than	NULL
using	NULL
an	NULL
internal	NULL
control	NULL
reporter	NULL
vector	NULL
(	NULL
37-39	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis-GH	NULL
,	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
rPRL	NULL
promoter-reporter	NULL
and	NULL
various	NULL
effector	NULL
plasmids	NULL
were	NULL
harvested	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
with	NULL
3	NULL
mM	NULL
EDTA	NULL
.	NULL

GH	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
sonication	NULL
using	NULL
five	NULL
10-s	NULL
pulses	NULL
on	NULL
ice	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.42	NULL
m	NULL
KCI	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.15	NULL
mM	NULL
spermine	NULL
,	NULL
0.5	NULL
mM	NULL
spermidine	NULL
,	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
0.45	NULL
mg/ml	NULL
Boehringer	NULL
Mannheim	NULL
protease	NULL
inhibitor	NULL
set	NULL
.	NULL

After	NULL
sonication	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
centrifuged	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

HeLa	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
rPRL	NULL
promoter	NULL
reporter	NULL
and	NULL
various	NULL
effector	NULL
plasmids	NULL
were	NULL
harvested	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
3	NULL
mM	NULL
EDTA	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
with	NULL
three	NULL
sequential	NULL
freeze-thaw	NULL
cycles	NULL
in	NULL
100	NULL
mM	NULL
potassium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
.	NULL

Vortexing	NULL
ensured	NULL
cell	NULL
lysis	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
spun	NULL
down	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
to	NULL
pellet	NULL
unlysed	NULL
cells	NULL
and	NULL
cell	NULL
debris	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
cellular	NULL
protein	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
in	NULL
192	NULL
mM	NULL
glycine	NULL
,	NULL
25	NULL
mM	NULL
Tris	NULL
,	NULL
10	NULL
%	NULL
methanol	NULL
at	NULL
100	NULL
mA	NULL
for	NULL
16	NULL
h.	NULL
Membranes	NULL
were	NULL
blocked	NULL
overnight	NULL
with	NULL
7.5	NULL
%	NULL
nonfat	NULL
dried	NULL
milk	NULL
in	NULL
20	NULL
mm	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
probed	NULL
with	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
c-Jun	NULL
antibody	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
95-105	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
;	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
GHF-1	NULL
antibody	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
214-230	NULL
(	NULL
BabCO	NULL
;	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
or	NULL
a	NULL
mouse	NULL
monoclonal	NULL
actin	NULL
antibody	NULL
,	NULL
clone	NULL
C4	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
in	NULL
a	NULL
1:1000	NULL
dilution	NULL
in	NULL
blocking	NULL
buffer	NULL
with	NULL
1	NULL
%	NULL
dried	NULL
milk	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
developed	NULL
with	NULL
a	NULL
1:5000	NULL
dilution	NULL
of	NULL
goat	NULL
anti-rabbit	NULL
or	NULL
goat	NULL
anti-mouse	NULL
antibodies	NULL
linked	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
Life	NULL
Technol-ogies	NULL
)	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
kit	NULL
from	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
Inc	NULL
.	NULL

Between	NULL
probes	NULL
with	NULL
different	NULL
antibodies	NULL
,	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
stripped	NULL
by	NULL
incubation	NULL
at	NULL
50	NULL
°C	NULL
for	NULL
30	NULL
min	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
0.7	NULL
%	NULL
B-mercaptoethanol	NULL
,	NULL
2	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
SDS	NULL
,	NULL
62.5	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
6.8	NULL
.	NULL

After	NULL
stripping	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
reblocked	NULL
overnight	NULL
,	NULL
and	NULL
the	NULL
membrane	NULL
was	NULL
then	NULL
reprobed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

In	NULL
Vitro	NULL
Protein	NULL
Binding	NULL
Studies-The	NULL
protein	NULL
A/GHF-1	NULL
fusion	NULL
(	NULL
pA/	NULL
GHF-1	NULL
)	NULL
vector	NULL
was	NULL
constructed	NULL
by	NULL
filling	NULL
in	NULL
,	NULL
with	NULL
Klenow	NULL
polymerase	NULL
,	NULL
the	NULL
Neo	NULL
!	NULL

to	NULL
NotI	NULL
fragment	NULL
of	NULL
the	NULL
GHF-1	NULL
clone	NULL
,	NULL
SK-9	NULL
(	NULL
47	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
ATG	NULL
codon	NULL
of	NULL
GHF-1	NULL
was	NULL
modified	NULL
to	NULL
an	NULL
Neo	NULL
!	NULL

site	NULL
and	NULL
the	NULL
Nof	NULL
]	NULL
site	NULL
is	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
downstream	NULL
of	NULL
the	NULL
stop	NULL
codon	NULL
.	NULL

The	NULL
blunt-ended	NULL
fragment	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
the	NULL
pA	NULL
vector	NULL
,	NULL
Rit	NULL
32	NULL
(	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
Rit	NULL
2	NULL
vector	NULL
)	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
amino-terminal	NULL
start	NULL
codon	NULL
of	NULL
GHF-1	NULL
is	NULL
thus	NULL
fused	NULL
,	NULL
in	NULL
frame	NULL
,	NULL
to	NULL
the	NULL
carboxyl	NULL
tail	NULL
of	NULL
protein	NULL
A	NULL
.	NULL

The	NULL
pA	NULL
and	NULL
pA/GHF-1	NULL
vectors	NULL
were	NULL
transformed	NULL
into	NULL
N4830-1	NULL
bacteria	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
grown	NULL
in	NULL
500	NULL
ml	NULL
of	NULL
Luria	NULL
broth	NULL
(	NULL
LB	NULL
)	NULL
at	NULL
30	NULL
°C	NULL
until	NULL
the	NULL
Ag	NULL
,	NULL
,	NULL
=	NULL
0.6	NULL
and	NULL
induced	NULL
with	NULL
0.1	NULL
mM	NULL
isopropyl-l-thio-B-D-galactopyranoside	NULL
and	NULL
increasing	NULL
the	NULL
temperature	NULL
to	NULL
42	NULL
°C	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
500	NULL
ml	NULL
of	NULL
LB	NULL
at	NULL
55	NULL
°C	NULL
;	NULL
the	NULL
N48830-1	NULL
bacteria	NULL
used	NULL
to	NULL
grow	NULL
the	NULL
pA	NULL
and	NULL
pA/GHF-1	NULL
constructs	NULL
contain	NULL
a	NULL
temperature-sensitive	NULL
A	NULL
cl	NULL
repressor	NULL
which	NULL
,	NULL
with	NULL
the	NULL
Lac	NULL
repressor	NULL
,	NULL
regulates	NULL
the	NULL
Rit32	NULL
promoter	NULL
.	NULL

The	NULL
pA-	NULL
and	NULL
pA/GHF-1-expressing	NULL
cells	NULL
were	NULL
collected	NULL
45	NULL
min	NULL
after	NULL
induction	NULL
,	NULL
since	NULL
pA/GHF-1	NULL
expression	NULL
was	NULL
quite	NULL
toxic	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

Bacterial	NULL
cell	NULL
pellets	NULL
were	NULL
resuspended	NULL
with	NULL
7-8	NULL
ml	NULL
of	NULL
TST	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
5	NULL
ug/ml	NULL
each	NULL
of	NULL
the	NULL
protease	NULL
inhibitors	NULL
antipain	NULL
,	NULL
chymostatin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
)	NULL
and	NULL
lysed	NULL
by	NULL
sonication	NULL
,	NULL
and	NULL
the	NULL
debris	NULL
was	NULL
pelleted	NULL
for	NULL
20	NULL
min	NULL
at	NULL
15,000	NULL
rpm	NULL
in	NULL
an	NULL
S834	NULL
rotor	NULL
.	NULL

The	NULL
pA-	NULL
and	NULL
pA/GHF-l-containing	NULL
lysates	NULL
were	NULL
then	NULL
passed	NULL
over	NULL
0.5	NULL
ml	NULL
of	NULL
IgG-agarose	NULL
(	NULL
Sigma	NULL
)	NULL
columns	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
TST	NULL
and	NULL
then	NULL
twice	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
25	NULL
mm	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
80	NULL
mM	NULL
KCl	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
listed	NULL
above	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
resuspended	NULL
with	NULL
1.5	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
and	NULL
stored	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Efficient	NULL
production	NULL
of	NULL
either	NULL
fusion	NULL
protein	NULL
was	NULL
assessed	NULL
by	NULL
boiling	NULL
approximately	NULL
10	NULL
pl	NULL
of	NULL
packed	NULL
beads	NULL
in	NULL
SDS	NULL
sample	NULL
loading	NULL
buffer	NULL
,	NULL
loading	NULL
onto	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
staining	NULL
with	NULL
Coomassie	NULL
Blue	NULL
.	NULL

Reticulocyte	NULL
lysates	NULL
(	NULL
Promega	NULL
)	NULL
were	NULL
programmed	NULL
with	NULL
RNA	NULL
transcribed	NULL
by	NULL
T7	NULL
polymerase	NULL
,	NULL
resulting	NULL
in	NULL
either	NULL
human	NULL
c-Jun	NULL
,	NULL
rat	NULL
c-Fos	NULL
,	NULL
or	NULL
rat	NULL
GHF-1	NULL
protein	NULL
labeled	NULL
with	NULL
[	NULL
*°S	NULL
]	NULL
Met	NULL
(	NULL
DuPont	NULL
NEN	NULL
)	NULL
.	NULL

Efficiency	NULL
of	NULL
labeling	NULL
was	NULL
assessed	NULL
by	NULL
electrophoresing	NULL
1	NULL
l	NULL
of	NULL
each	NULL
sample	NULL
on	NULL
an	NULL
SDS	NULL
protein	NULL
gel	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Roughly	NULL
equivalent	NULL
amounts	NULL
of	NULL
each	NULL
radiolabeled	NULL
protein	NULL
(	NULL
2-5	NULL
pl	NULL
of	NULL
each	NULL
programmed	NULL
reticulocyte	NULL
lysate	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
about	NULL
5	NULL
pl	NULL
of	NULL
packed	NULL
pA	NULL
or	NULL
pA/GHF-1	NULL
beads	NULL
in	NULL
100	NULL
wl	NULL
of	NULL
buffer	NULL
A	NULL
containing	NULL
0.05	NULL
%	NULL
Nonidet	NULL
P-40	NULL
and	NULL
200	NULL
pg/ml	NULL
ethidium	NULL
bromide	NULL
(	NULL
52	NULL
)	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
gentle	NULL
rocking	NULL
in	NULL
an	NULL
Eppendorf	NULL
tube	NULL
.	NULL

Unprogrammed	NULL
reticulocyte	NULL
lysate	NULL
was	NULL
added	NULL
to	NULL
each	NULL
incubation	NULL
so	NULL
that	NULL
all	NULL
incubations	NULL
were	NULL
done	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
lysate	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
the	NULL
beads	NULL
were	NULL
pelleted	NULL
,	NULL
the	NULL
supernatant	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
washed	NULL
six	NULL
additional	NULL
times	NULL
each	NULL
with	NULL
170	NULL
ul	NULL
of	NULL
buffer	NULL
A	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

To	NULL
each	NULL
pellet	NULL
or	NULL
input	NULL
sample	NULL
was	NULL
added	NULL
15	NULL
pl	NULL
of	NULL
SDS	NULL
gel	NULL
loading	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
boiled	NULL
and	NULL
loaded	NULL
onto	NULL
an	NULL
SDS	NULL
83	NULL
%	NULL
stacking	NULL
,	NULL
10	NULL
%	NULL
resolving	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
the	NULL
signal	NULL
was	NULL
enhanced	NULL
with	NULL
``	NULL
Amplify	NULL
``	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
c-Jun	NULL
Selectively	NULL
Inhibits	NULL
the	NULL
rPRL	NULL
Promoter	NULL
in	NULL
a	NULL
Dose-responsive	NULL
Fashion-Since	NULL
c-Jun	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
basal	NULL
rPRL	NULL
promoter	NULL
activity	NULL
(	NULL
41	NULL
)	NULL
,	NULL
we	NULL
first	NULL
tested	NULL
whether	NULL
this	NULL
effect	NULL
was	NULL
dose-responsive	NULL
on	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
c-Jun	NULL
produced	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
the	NULL
-425-base	NULL
pair	NULL
rPRL	NULL
promoter	NULL
reaching	NULL
58	NULL
%	NULL
inhibition	NULL
at	NULL
a	NULL
dose	NULL
of	NULL
20	NULL
ug	NULL
of	NULL
pRSVce-jun	NULL
.	NULL

Although	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
c-Jun	NULL
is	NULL
modest	NULL
,	NULL
it	NULL
is	NULL
very	NULL
reproducible	NULL
and	NULL
statistically	NULL
significant	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
similar	NULL
doses	NULL
of	NULL
pRSVc-jun	NULL
inhibited	NULL
a	NULL
-2.5	NULL
kilobase	NULL
pair	NULL
rPRL	NULL
promoter	NULL
construct	NULL
,	NULL
containing	NULL
the	NULL
distal	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
maximal	NULL
dose	NULL
of	NULL
pRSVc-jun	NULL
,	NULL
20	NULL
ug	NULL
,	NULL
was	NULL
then	NULL
used	NULL
in	NULL
all	NULL
further	NULL
studies	NULL
.	NULL

The	NULL
inhibition	NULL
of	NULL
the	NULL
-425	NULL
rPRL	NULL
promoter	NULL
by	NULL
c-Jun	NULL
reached	NULL
50	NULL
%	NULL
by	NULL
12	NULL
h	NULL
post-transfection	NULL
and	NULL
remained	NULL
constant	NULL
from	NULL
12	NULL
to	NULL
24	NULL
h	NULL
post-transfection	NULL
,	NULL
with	NULL
maximal	NULL
inhibition	NULL
reaching	NULL
77	NULL
%	NULL
at	NULL
36	NULL
h	NULL
post-transfection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
ensure	NULL
that	NULL
the	NULL
transiently	NULL
transfected	NULL
c-Jun	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
detectable	NULL
levels	NULL
of	NULL
c-Jun	NULL
protein	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
control	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
and	NULL
mock-transfected	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
GH	NULL
,	NULL
cells	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
have	NULL
detectable	NULL
levels	NULL
endogenous	NULL
c-Jun	NULL
,	NULL
whereas	NULL
transfection	NULL
of	NULL
pRSVc-jun	NULL
resulted	NULL
in	NULL
readily	NULL
detectable	NULL
levels	NULL
of	NULL
c-Jun	NULL
protein	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
an	NULL
anti-GHF-1	NULL
antibody	NULL
in	NULL
order	NULL
to	NULL
verify	NULL
that	NULL
the	NULL
proteins	NULL
in	NULL
the	NULL
cellular	NULL
extract	NULL
loaded	NULL
in	NULL
Zanes	NULL
1-3	NULL
were	NULL
equivalent	NULL
and	NULL
intact	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
GHF-1	NULL
protein	NULL
17141	NULL
A	NULL
1.2	NULL
fal	NULL
ig	NULL
0	NULL
14	NULL
o	NULL
g	NULL
a	NULL
.	NULL

%	NULL
-8	NULL
o6-£	NULL
0.4	NULL
$	NULL
04-	NULL
.	NULL

0.2	NULL
0	NULL
I	NULL
U	NULL
I	NULL
I	NULL
T	NULL
0	NULL
2	NULL
5	NULL
10	NULL
15	NULL
20	NULL
pRSVe-jun	NULL
(	NULL
ig	NULL
)	NULL
B	NULL
10	NULL
2	NULL
%	NULL
3	NULL
40005	NULL
6	NULL
<	NULL
4-	NULL
46	NULL
kDa	NULL
wie	NULL
<	NULL
-	NULL
GHF-1	NULL
meme	NULL
<	NULL
4-	NULL
c-Jun	NULL
g	NULL
<	NULL
-	NULL
30	NULL
kDa	NULL
Anti-c-Jun	NULL
95-105	NULL
Anti-GHP-1	NULL
214-230	NULL
Fig	NULL
.	NULL

1.	NULL
c-Jun	NULL
inhibits	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
.	NULL

A	NULL
,	NULL
c-Jun	NULL
dose	NULL
response	NULL
.	NULL

Exponentially	NULL
growing	NULL
GH	NULL
,	NULL
rat	NULL
pituitary	NULL
tumor	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
triplicate	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
pA	NULL
,	NULL
PRLIluc-425	NULL
and	NULL
with	NULL
or	NULL
without	NULL
2	NULL
,	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
or	NULL
20	NULL
ug	NULL
of	NULL
pRSVe-jun	NULL
.	NULL

An	NULL
equal	NULL
amount	NULL
of	NULL
pRSV	NULL
-globin	NULL
was	NULL
added	NULL
to	NULL
control	NULL
for	NULL
nonspecific	NULL
promoter	NULL
effects	NULL
as	NULL
well	NULL
as	NULL
to	NULL
maintain	NULL
total	NULL
DNA	NULL
equivalent	NULL
in	NULL
all	NULL
transfections	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Pro-cedures	NULL
.	NULL
``	NULL

The	NULL
fold	NULL
basal	NULL
rPRL	NULL
promoter	NULL
activity	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
mean	NULL
total	NULL
light	NULL
units	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pRSVc-jun	NULL
by	NULL
the	NULL
mean	NULL
total	NULL
light	NULL
units	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pRSV	NULL
-globin	NULL
alone	NULL
.	NULL

Different	NULL
plasmid	NULL
preparations	NULL
were	NULL
used	NULL
for	NULL
separate	NULL
experiments	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
-fold	NULL
+	NULL
S.E	NULL
.	NULL

for	NULL
three	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
,	NULL
and	NULL
specific	NULL
comparisons	NULL
of	NULL
the	NULL
means	NULL
were	NULL
conducted	NULL
by	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
.	NULL

The	NULL
results	NULL
for	NULL
DNA	NULL
doses	NULL
of	NULL
5	NULL
and	NULL
20	NULL
were	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.05	NULL
,	NULL
and	NULL
10	NULL
and	NULL
15	NULL
were	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.01	NULL
.	NULL

B	NULL
,	NULL
c-Jun	NULL
Western	NULL
blot	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
of	NULL
cell	NULL
protein	NULL
from	NULL
transfected	NULL
GH	NULL
,	NULL
cells	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
e-Jun/	NULL
AP-1	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
and	NULL
detected	NULL
using	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
5-min	NULL
exposure	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
GHF-1	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
and	NULL
detected	NULL
using	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
30-min	NULL
exposure	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
4	NULL
,	NULL
wild-type	NULL
GH	NULL
,	NULL
cells	NULL
untrans-fected	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
,	NULL
GH	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
empty	NULL
pRSVB-globin	NULL
vector	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
,	NULL
GH	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
pRSVe-jun	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
size	NULL
standards	NULL
of	NULL
46	NULL
kDa	NULL
(	NULL
ovalbumin	NULL
)	NULL
and	NULL
30	NULL
kDa	NULL
(	NULL
carbonic	NULL
anhydrase	NULL
)	NULL
.	NULL

were	NULL
equivalent	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
c-Jun	NULL
expression	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
GHF-1	NULL
protein	NULL
levels	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
negative	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
rPRL	NULL
promoter	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
endogenous	NULL
GHF-1	NULL
protein	NULL
levels	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
was	NULL
promoter-specific	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
c-Jun	NULL
was	NULL
examined	NULL
on	NULL
a	NULL
variety	NULL
of	NULL
pituitary	NULL
and	NULL
nonpituitary	NULL
promoters	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
c-Jun	NULL
inhibited	NULL
the	NULL
-425	NULL
rPRL	NULL
promoter	NULL
and	NULL
the	NULL
-2.5	NULL
kilobase	NULL
pair	NULL
rPRL	NULL
promoter	NULL
54	NULL
and	NULL
34	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
pituitary-specific	NULL
growth	NULL
hormone	NULL
promoter	NULL
was	NULL
also	NULL
inhibited	NULL
by	NULL
c-Jun	NULL
to	NULL
53	NULL
%	NULL
of	NULL
its	NULL
basal	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
c-Jun	NULL
was	NULL
not	NULL
a	NULL
general	NULL
inhibitor	NULL
of	NULL
pituitary	NULL
promoters	NULL
as	NULL
evidenced	NULL
by	NULL
its	NULL
1.7-fold	NULL
stimulation	NULL
of	NULL
the	NULL
human	NULL
glycoprotein	NULL
a-subunit	NULL
promoter	NULL
.	NULL

Also	NULL
,	NULL
c-Jun	NULL
stimulated	NULL
the	NULL
c-fosTK	NULL
promoter	NULL
,	NULL
containing	NULL
a	NULL
consensus	NULL
AP-1	NULL
binding	NULL
site	NULL
,	NULL
by	NULL
1.9-fold	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
c-Jun	NULL
on	NULL
several	NULL
viral	NULL
promoters	NULL
in	NULL
the	NULL
GH	NULL
,	NULL
cells	NULL
also	NULL
varied	NULL
,	NULL
with	NULL
the	NULL
CMV	NULL
promoter	NULL
inhibited	NULL
45	NULL
%	NULL
by	NULL
c-Jun	NULL
,	NULL
whereas	NULL
the	NULL
SV40	NULL
and	NULL
RSV	NULL
promoters	NULL
were	NULL
stimulated	NULL
2.1-	NULL
and	NULL
2.4-fold	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
promoterless	NULL
pA	NULL
;	NULL
luc	NULL
reporter	NULL
vector	NULL
,	NULL
used	NULL
as	NULL
the	NULL
parental	NULL
reporter	NULL
was	NULL
minimal	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
c-Jun	NULL
inhibition	NULL
was	NULL
promoter-selective	NULL
for	NULL
rPRL	NULL
,	NULL
rGH	NULL
,	NULL
and	NULL
CMV	NULL
and	NULL
that	NULL
the	NULL
neg-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
17142	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
H1	NULL
bd	NULL
3	NULL
wo	NULL
ls	NULL
¢§°w5	NULL
>	NULL
m	NULL
§	NULL
?	NULL

2	NULL
af	NULL
+	NULL
pRSVc-jun	NULL
Fic	NULL
.	NULL

2.	NULL
c-Jun	NULL
differentially	NULL
modulates	NULL
various	NULL
pituitary	NULL
and	NULL
viral	NULL
promoters	NULL
in	NULL
GH	NULL
,	NULL
pituitary	NULL
cells	NULL
.	NULL

GH	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pA	NULL
,	NULL
PRLluc-425	NULL
,	NULL
p2.5kbPRLlue	NULL
,	NULL
prGHlue	NULL
,	NULL
pHeluc-1760	NULL
,	NULL
pe-fosTKlue	NULL
,	NULL
pCMVlue	NULL
,	NULL
pSV40luc	NULL
,	NULL
pA	NULL
,	NULL
RSVluc400	NULL
,	NULL
or	NULL
pA	NULL
,	NULL
lue	NULL
with	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
-globin	NULL
or	NULL
pRSVe-jun	NULL
.	NULL

-Fold	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
each	NULL
individual	NULL
promoter	NULL
construct	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
-fold	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
eight	NULL
transfections	NULL
for	NULL
pA	NULL
,	NULL
PRLluc-425	NULL
,	NULL
six	NULL
transfections	NULL
for	NULL
p2.5kbPRLIluc	NULL
,	NULL
four	NULL
transfections	NULL
for	NULL
prGHlue	NULL
,	NULL
three	NULL
transfections	NULL
for	NULL
pHaluc-1760	NULL
,	NULL
two	NULL
transfections	NULL
for	NULL
pe-fosTKlue	NULL
,	NULL
five	NULL
transfections	NULL
for	NULL
pCMVluc	NULL
,	NULL
five	NULL
transfections	NULL
for	NULL
pSV40luc	NULL
,	NULL
three	NULL
transfections	NULL
of	NULL
pRSVluc400	NULL
,	NULL
and	NULL
three	NULL
transfections	NULL
for	NULL
pA	NULL
,	NULL
lue	NULL
.	NULL

Each	NULL
experiment	NULL
consisted	NULL
of	NULL
transfections	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
c-Jun	NULL
on	NULL
both	NULL
the	NULL
-425	NULL
and	NULL
the	NULL
-2.5	NULL
kilobase	NULL
pair	NULL
rPRL	NULL
promoters	NULL
were	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.01	NULL
,	NULL
whereas	NULL
the	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
parental	NULL
pA	NULL
,	NULL
lue	NULL
vector	NULL
was	NULL
not	NULL
statistically	NULL
significant	NULL
compared	NULL
with	NULL
untreated	NULL
.	NULL

ative	NULL
effect	NULL
was	NULL
not	NULL
mediated	NULL
by	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
pAglue	NULL
vector	NULL
background	NULL
.	NULL

c-Jun	NULL
Inhibition	NULL
Maps	NULL
to	NULL
the	NULL
FP	NULL
II	NULL
Region	NULL
of	NULL
the	NULL
rPRL	NULL
Pro-moter-In	NULL
order	NULL
to	NULL
address	NULL
the	NULL
question	NULL
of	NULL
mechanism	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
which	NULL
region	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
was	NULL
important	NULL
for	NULL
mediating	NULL
this	NULL
c-Jun	NULL
inhibition	NULL
.	NULL

In	NULL
the	NULL
rPRL	NULL
promoter	NULL
,	NULL
footprints	NULL
(	NULL
FPs	NULL
)	NULL
I	NULL
,	NULL
III	NULL
,	NULL
and	NULL
IV	NULL
bind	NULL
GHF-1/Pit-1	NULL
,	NULL
a	NULL
pituitary-specific	NULL
POU-homeodomain	NULL
transactivator	NULL
(	NULL
36	NULL
,	NULL
53	NULL
)	NULL
.	NULL

FP	NULL
II	NULL
binds	NULL
a	NULL
ubiquitous	NULL
repressor	NULL
denoted	NULL
as	NULL
F2F	NULL
,	NULL
and	NULL
the	NULL
-117	NULL
to	NULL
-80	NULL
BTE	NULL
binds	NULL
a	NULL
ubiquitous	NULL
basal	NULL
transcription-acti-vating	NULL
factor	NULL
,	NULL
both	NULL
of	NULL
which	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
characterized	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
series	NULL
of	NULL
5	NULL
deletions	NULL
and	NULL
site-specific	NULL
mutations	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
impinging	NULL
on	NULL
these	NULL
various	NULL
regulatory	NULL
cis-acting	NULL
sites	NULL
(	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
we	NULL
show	NULL
that	NULL
c-Jun	NULL
equally	NULL
inhibited	NULL
rPRL	NULL
promoter	NULL
constructs	NULL
with	NULL
5	NULL
end	NULL
points	NULL
of	NULL
-425	NULL
,	NULL
-255	NULL
,	NULL
and	NULL
-189	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
c-Jun	NULL
switched	NULL
to	NULL
an	NULL
activating	NULL
response	NULL
with	NULL
rPRL	NULL
promoter	NULL
5	NULL
'	NULL
end	NULL
points	NULL
of	NULL
-125	NULL
,	NULL
-54	NULL
,	NULL
and	NULL
-36	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
statistical	NULL
analysis	NULL
(	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
)	NULL
revealed	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
c-Jun	NULL
are	NULL
statistically	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.05	NULL
for	NULL
the	NULL
-425	NULL
and	NULL
-125	NULL
end	NULL
points	NULL
and	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.01	NULL
for	NULL
the	NULL
-255	NULL
and	NULL
-189	NULL
end	NULL
points	NULL
,	NULL
whereas	NULL
the	NULL
effects	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
-54	NULL
,	NULL
-36	NULL
,	NULL
and	NULL
promoterless	NULL
constructs	NULL
were	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
DNA	NULL
sequences	NULL
between	NULL
-189	NULL
and	NULL
-125	NULL
were	NULL
responsible	NULL
for	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
c-Jun	NULL
,	NULL
while	NULL
sequences	NULL
between	NULL
-125	NULL
and	NULL
-54	NULL
were	NULL
responsible	NULL
for	NULL
c-Jun	NULL
's	NULL
activating	NULL
effect	NULL
.	NULL

Moreover	NULL
,	NULL
neither	NULL
the	NULL
negative	NULL
nor	NULL
positive	NULL
effects	NULL
of	NULL
c-Jun	NULL
were	NULL
due	NULL
to	NULL
a	NULL
cryptic	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
pA	NULL
;	NULL
lue	NULL
background	NULL
vector	NULL
,	NULL
since	NULL
c-Jun	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
pA	NULL
;	NULL
glue	NULL
promoterless	NULL
vector	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3B	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
-189	NULL
to	NULL
-125	NULL
region	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
lie	NULL
both	NULL
FP	NULL
III	NULL
and	NULL
FP	NULL
II	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
which	NULL
of	NULL
these	NULL
two	NULL
footprints	NULL
was	NULL
important	NULL
for	NULL
c-Jun	NULL
action	NULL
,	NULL
we	NULL
used	NULL
a	NULL
panel	NULL
of	NULL
site-specific	NULL
mutants	NULL
that	NULL
featured	NULL
a	NULL
Sail	NULL
linker	NULL
sequence	NULL
substituted	NULL
for	NULL
specific	NULL
bases	NULL
within	NULL
the	NULL
various	NULL
footprints	NULL
and	NULL
a	NULL
6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
site-specific	NULL
deletion	NULL
of	NULL
the	NULL
BTE	NULL
in	NULL
a	NULL
FP	NULL
II	NULL
mutant	NULL
background	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
mutations	NULL
in	NULL
FPs	NULL
I	NULL
and	NULL
III	NULL
,	NULL
the	NULL
A1	NULL
and	NULL
A1,3	NULL
mutants	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
c-Jun-mediated	NULL
inhibition	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
,	NULL
excluding	NULL
these	NULL
sites	NULL
as	NULL
DNA	NULL
targets	NULL
of	NULL
the	NULL
c-Jun	NULL
inhibitory	NULL
effect	NULL
.	NULL

Indeed	NULL
,	NULL
these	NULL
two	NULL
mutant	NULL
promoters	NULL
were	NULL
inhibited	NULL
to	NULL
a	NULL
greater	NULL
extent	NULL
by	NULL
c-Jun	NULL
,	NULL
perhaps	NULL
because	NULL
of	NULL
the	NULL
disruption	NULL
of	NULL
GHF-1	NULL
activating	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
mutation	NULL
of	NULL
FP	NULL
II	NULL
,	NULL
in	NULL
either	NULL
the	NULL
A2	NULL
or	NULL
A2	NULL
,	NULL
D	NULL
constructs	NULL
,	NULL
led	NULL
to	NULL
a	NULL
loss	NULL
of	NULL
inhibition	NULL
,	NULL
thereby	NULL
mapping	NULL
the	NULL
c-Jun	NULL
effect	NULL
to	NULL
FP	NULL
II	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
5	NULL
deletion	NULL
data	NULL
,	NULL
showing	NULL
that	NULL
disruption	NULL
of	NULL
FP	NULL
II	NULL
in	NULL
the	NULL
-125	NULL
and	NULL
shorter	NULL
constructs	NULL
eliminated	NULL
the	NULL
repressing	NULL
effect	NULL
of	NULL
c-Jun	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Removal	NULL
of	NULL
the	NULL
8-Domain	NULL
Switches	NULL
c-Jun	NULL
from	NULL
an	NULL
Inhibitor	NULL
to	NULL
an	NULL
Activator-In	NULL
order	NULL
to	NULL
investigate	NULL
potential	NULL
structure-function	NULL
correlations	NULL
as	NULL
they	NULL
related	NULL
to	NULL
mechanism	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
which	NULL
domains	NULL
of	NULL
the	NULL
c-Jun	NULL
protein	NULL
were	NULL
required	NULL
to	NULL
mediate	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

As	NULL
shown	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
the	NULL
c-Jun	NULL
protein	NULL
consists	NULL
of	NULL
five	NULL
major	NULL
domains	NULL
.	NULL

The	NULL
8-domain	NULL
is	NULL
important	NULL
for	NULL
protein-protein	NULL
inter-actions	NULL
,	NULL
including	NULL
the	NULL
interaction	NULL
with	NULL
Jun	NULL
kinase	NULL
(	NULL
18	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
there	NULL
are	NULL
two	NULL
functionally	NULL
determined	NULL
transactivation	NULL
domains	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
there	NULL
is	NULL
a	NULL
basic	NULL
domain	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
a	NULL
COOH-terminal	NULL
leucine	NULL
zipper	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
important	NULL
for	NULL
protein	NULL
dimerization	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
data	NULL
indicating	NULL
that	NULL
the	NULL
8-domain	NULL
plays	NULL
an	NULL
important	NULL
regulatory	NULL
role	NULL
,	NULL
modulating	NULL
c-Jun	NULL
's	NULL
transactivation	NULL
potential	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
(	NULL
9	NULL
,	NULL
20-23	NULL
)	NULL
,	NULL
we	NULL
chose	NULL
to	NULL
use	NULL
a	NULL
v-Jun	NULL
construct	NULL
,	NULL
which	NULL
differs	NULL
from	NULL
c-Jun	NULL
in	NULL
that	NULL
it	NULL
lacks	NULL
the	NULL
NH-terminal	NULL
8-domain	NULL
and	NULL
contains	NULL
three	NULL
COOH-terminal	NULL
point	NULL
mutations	NULL
(	NULL
9	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
pRSVv-jun	NULL
had	NULL
the	NULL
opposite	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
intact	NULL
-425	NULL
rPRL	NULL
promoter	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
,	NULL
producing	NULL
a	NULL
12.9-fold	NULL
promoter	NULL
stimulation	NULL
,	NULL
whereas	NULL
c-Jun	NULL
resulted	NULL
in	NULL
a	NULL
42	NULL
%	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
loss	NULL
of	NULL
the	NULL
8-domain	NULL
provides	NULL
a	NULL
functional	NULL
switch	NULL
,	NULL
turning	NULL
v-Jun	NULL
into	NULL
an	NULL
activator	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
equal	NULL
amounts	NULL
of	NULL
transfected	NULL
plasmids	NULL
produced	NULL
equivalent	NULL
amounts	NULL
of	NULL
expressed	NULL
Jun	NULL
pro-tein	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
Jun	NULL
antibody	NULL
capable	NULL
of	NULL
recognizing	NULL
both	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
c-Jun	NULL
was	NULL
actually	NULL
produced	NULL
in	NULL
slightly	NULL
greater	NULL
amounts	NULL
than	NULL
v-Jun	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
endogenous	NULL
GHF-1	NULL
in	NULL
these	NULL
transfected	NULL
cells	NULL
were	NULL
unaffected	NULL
by	NULL
c-Jun	NULL
and	NULL
mildly	NULL
stimulated	NULL
by	NULL
v-Jun	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
differences	NULL
in	NULL
c-Jun	NULL
or	NULL
v-Jun	NULL
protein	NULL
production	NULL
are	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
specific	NULL
effects	NULL
of	NULL
each	NULL
Jun	NULL
construct	NULL
.	NULL

The	NULL
Absence	NULL
of	NULL
Pituitary-specific	NULL
Factor	NULL
(	NULL
s	NULL
)	NULL
Switches	NULL
c-Jun	NULL
from	NULL
an	NULL
Inhibitor	NULL
to	NULL
an	NULL
Activator	NULL
of	NULL
the	NULL
rPRL	NULL
Promoter-Since	NULL
the	NULL
8-domain	NULL
of	NULL
c-Jun	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
cell-specific	NULL
modulation	NULL
of	NULL
both	NULL
transcription	NULL
and	NULL
transformation	NULL
(	NULL
9	NULL
,	NULL
20-23	NULL
)	NULL
and	NULL
we	NULL
documented	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
3-domain	NULL
modulates	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
c-Jun	NULL
in	NULL
GH	NULL
,	NULL
pituitary	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
we	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
on	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
nonpituitary	NULL
Hela	NULL
human	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
.	NULL

To	NULL
address	NULL
these	NULL
points	NULL
,	NULL
we	NULL
used	NULL
a	NULL
nonpituitary	NULL
gene	NULL
transfer	NULL
reconstitution	NULL
system	NULL
,	NULL
whereby	NULL
the	NULL
ability	NULL
of	NULL
co-transfected	NULL
effector	NULL
expression	NULL
vectors	NULL
(	NULL
eg	NULL
.	NULL

GHF-1	NULL
)	NULL
to	NULL
reconstitute	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
which	NULL
otherwise	NULL
fail	NULL
to	NULL
express	NULL
endogenous	NULL
PRL	NULL
or	NULL
GHF-1	NULL
,	NULL
can	NULL
be	NULL
determined	NULL
(	NULL
45	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
transfected	NULL
GHF-1	NULL
alone	NULL
stimulated	NULL
rPRL	NULL
promoter	NULL
activity	NULL
by	NULL
21.3-fold	NULL
,	NULL
verifying	NULL
that	NULL
the	NULL
reconstitution	NULL
approach	NULL
is	NULL
functional	NULL
.	NULL

Surprisingly	NULL
,	NULL
co-transfection	NULL
with	NULL
c-Jun	NULL
alone	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
rPRL	NULL
promoter	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
,	NULL
but	NULL
instead	NULL
c-Jun	NULL
activated	NULL
the	NULL
rPRL	NULL
promoter	NULL
2.6-fold	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
c-Jun	NULL
inhibition	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
noted	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
is	NULL
pituitary	NULL
cell-specific	NULL
.	NULL

Moreover	NULL
,	NULL
when	NULL
c-Jun	NULL
and	NULL
GHF-1	NULL
expression	NULL
vec-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
A	NULL
-255	NULL
+189	NULL
-125	NULL
0-54-36	NULL
-425	NULL
M	NULL
a	NULL
v	NULL
425	NULL
+73	NULL
AA	NULL
__	NULL
=	NULL
<	NULL
+73	NULL
+73	NULL
+73	NULL
AL,3	NULL
e	NULL
171483	NULL
B	NULL
_	NULL
5	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
425	NULL
-255	NULL
-189	NULL
-125	NULL
-54	NULL
+	NULL
pRSV	NULL
c-jun	NULL
-36	NULL
pA3luc	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
~425	NULL
Al	NULL
AZ	NULL
A2	NULL
,	NULL
D	NULL
_	NULL
Al,3	NULL
+	NULL
pRSV	NULL
c-jun	NULL
Fic	NULL
.	NULL

3.	NULL
c-Jun	NULL
inhibition	NULL
maps	NULL
to	NULL
the	NULL
FP	NULL
II	NULL
region	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
structural	NULL
organization	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

A	NULL
graphic	NULL
representation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
from	NULL
-425	NULL
to	NULL
+73	NULL
is	NULL
depicted	NULL
.	NULL

The	NULL
end	NULL
points	NULL
of	NULL
5	NULL
exonuclease	NULL
deletions	NULL
constructed	NULL
in	NULL
pA	NULL
,	NULL
lue	NULL
are	NULL
denoted	NULL
by	NULL
arrows	NULL
and	NULL
have	NULL
been	NULL
verified	NULL
by	NULL
dideoxy	NULL
sequencing	NULL
.	NULL
``	NULL

GHF-1	NULL
sites	NULL
(	NULL
FP	NULL
I	NULL
,	NULL
FP	NULL
III	NULL
,	NULL
FP	NULL
IV	NULL
)	NULL
as	NULL
determined	NULL
by	NULL
DNase	NULL
protection	NULL
assay	NULL
(	NULL
53	NULL
)	NULL
are	NULL
shown	NULL
with	NULL
the	NULL
stippled	NULL
squares	NULL
.	NULL

The	NULL
FP	NULL
II	NULL
repressor	NULL
site	NULL
(	NULL
F2F	NULL
)	NULL
and	NULL
the	NULL
BTE	NULL
(	NULL
43	NULL
)	NULL
are	NULL
denoted	NULL
by	NULL
the	NULL
striped	NULL
circle	NULL
and	NULL
hatched	NULL
oval	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
site-specific	NULL
rPRL	NULL
promoter	NULL
mutants	NULL
include	NULL
1	NULL
)	NULL
the	NULL
A1	NULL
site-specific	NULL
mutant	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
rectangle	NULL
in	NULL
the	NULL
FP	NULL
I	NULL
region	NULL
to	NULL
yield	NULL
pA	NULL
,	NULL
Allue	NULL
;	NULL
2	NULL
)	NULL
the	NULL
AZ	NULL
site-specific	NULL
mutant	NULL
indicated	NULL
by	NULL
the	NULL
black	NULL
rectangle	NULL
in	NULL
the	NULL
FP	NULL
II	NULL
region	NULL
to	NULL
yield	NULL
pA	NULL
,	NULL
AZlue	NULL
;	NULL
3	NULL
)	NULL
the	NULL
A2	NULL
,	NULL
D	NULL
site-specific	NULL
deletion	NULL
mutant	NULL
containing	NULL
a	NULL
32-base	NULL
pair	NULL
deletion	NULL
of	NULL
the	NULL
-112	NULL
to	NULL
-80	NULL
BTE	NULL
region	NULL
in	NULL
the	NULL
AZ	NULL
background	NULL
to	NULL
yield	NULL
pA	NULL
,	NULL
A2	NULL
,	NULL
Dluc	NULL
;	NULL
and	NULL
4	NULL
)	NULL
the	NULL
A1,8	NULL
site-specific	NULL
mutant	NULL
indicated	NULL
by	NULL
the	NULL
open	NULL
rectangles	NULL
in	NULL
both	NULL
the	NULL
FP	NULL
I	NULL
and	NULL
FP	NULL
III	NULL
regions	NULL
to	NULL
yield	NULL
pA	NULL
,	NULL
A1,83luc	NULL
.	NULL

B	NULL
,	NULL
c-Jun	NULL
repression	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
maps	NULL
between	NULL
-189	NULL
and	NULL
-125	NULL
base	NULL
pairs	NULL
.	NULL

The	NULL
indicated	NULL
rPRL	NULL
promoter	NULL
deletions	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
GH	NULL
,	NULL
cells	NULL
with	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
pRSV	NULL
-globin	NULL
or	NULL
pRSVe-jun	NULL
.	NULL

-Fold	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
each	NULL
individual	NULL
promoter	NULL
construct	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
fold	NULL
for	NULL
four	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

Statistical	NULL
analysis	NULL
(	NULL
student	NULL
¢	NULL
test	NULL
)	NULL
reveal	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
c-Jun	NULL
are	NULL
significant	NULL
to	NULL
p	NULL
<	NULL
0.05	NULL
for	NULL
the	NULL
-425	NULL
and	NULL
-125	NULL
end	NULL
points	NULL
and	NULL
to	NULL
p	NULL
<	NULL
0.01	NULL
for	NULL
the	NULL
-255	NULL
and	NULL
-189	NULL
end	NULL
points	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
-54	NULL
,	NULL
-36	NULL
,	NULL
and	NULL
promoterless	NULL
constructs	NULL
were	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

C	NULL
,	NULL
c-Jun	NULL
repression	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
maps	NULL
to	NULL
the	NULL
FP	NULL
II	NULL
region	NULL
.	NULL

The	NULL
indicated	NULL
rPRL	NULL
site-specific	NULL
mutants	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
GH	NULL
,	NULL
cells	NULL
with	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
pRSVB-globin	NULL
or	NULL
pRSVe-jun	NULL
.	NULL

-Fold	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
each	NULL
individual	NULL
promoter	NULL
construct	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
-fold	NULL
+	NULL
S.E	NULL
.	NULL

for	NULL
three	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

tors	NULL
were	NULL
co-transfected	NULL
into	NULL
Hela	NULL
cells	NULL
,	NULL
a	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
of	NULL
131-fold	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
v-Jun	NULL
alone	NULL
stimulated	NULL
the	NULL
rPRL	NULL
promoter	NULL
only	NULL
slightly	NULL
(	NULL
1.5-fold	NULL
)	NULL
,	NULL
compared	NULL
with	NULL
its	NULL
effects	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
(	NULL
12.8-fold	NULL
;	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
v-Jun	NULL
also	NULL
synergized	NULL
with	NULL
GHF-1	NULL
to	NULL
stimulate	NULL
the	NULL
rPRL	NULL
promoter	NULL
43.5-fold	NULL
.	NULL

Western	NULL
blot	NULL
analy-sis	NULL
,	NULL
internally	NULL
controlled	NULL
for	NULL
actin	NULL
protein	NULL
levels	NULL
,	NULL
demonstrated	NULL
that	NULL
the	NULL
transfected	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
expression	NULL
vectors	NULL
resulted	NULL
in	NULL
comparable	NULL
protein	NULL
levels	NULL
in	NULL
Hela	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
in	NULL
a	NULL
nonpituitary	NULL
cell	NULL
background	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
rPRL	NULL
promoter	NULL
is	NULL
switched	NULL
to	NULL
that	NULL
of	NULL
an	NULL
activator	NULL
,	NULL
whereas	NULL
v-Jun	NULL
functions	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
both	NULL
pituitary	NULL
and	NULL
nonpituitary	NULL
cells	NULL
,	NULL
underscoring	NULL
that	NULL
the	NULL
functional	NULL
effect	NULL
of	NULL
the	NULL
8-domain	NULL
is	NULL
cell	NULL
type-specific	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
c-Jun	NULL
is	NULL
unlikely	NULL
to	NULL
inhibit	NULL
rPRL	NULL
promoter	NULL
activity	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
by	NULL
interfering	NULL
with	NULL
GHF-L.	NULL
Having	NULL
shown	NULL
that	NULL
c-Jun	NULL
alone	NULL
activated	NULL
rPRL	NULL
promoter	NULL
activity	NULL
and	NULL
synergized	NULL
with	NULL
GHF-1	NULL
to	NULL
further	NULL
enhance	NULL
rPRL	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
HeLa	NULL
nonpituitary	NULL
cell	NULL
system	NULL
,	NULL
we	NULL
next	NULL
sought	NULL
to	NULL
map	NULL
the	NULL
cis-acting	NULL
element	NULL
mediating	NULL
the	NULL
c-Jun	NULL
activation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
activating	NULL
effect	NULL
of	NULL
c-Jun	NULL
on	NULL
the	NULL
intact	NULL
-425	NULL
rPRL	NULL
promoter	NULL
(	NULL
3.5-fold	NULL
)	NULL
was	NULL
lost	NULL
upon	NULL
site-specific	NULL
mutation	NULL
of	NULL
FP	NULL
I	NULL
,	NULL
either	NULL
alone	NULL
(	NULL
1.2-fold	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
FP	NULL
III	NULL
mutation	NULL
(	NULL
1.2-fold	NULL
)	NULL
;	NULL
whereas	NULL
mutation	NULL
of	NULL
FP	NULL
II	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
c-Jun	NULL
to	NULL
activate	NULL
rPRL	NULL
promoter	NULL
(	NULL
3.8-fold	NULL
)	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
data	NULL
from	NULL
GH	NULL
,	NULL
cells	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
activating	NULL
effects	NULL
of	NULL
c-Jun	NULL
co-localize	NULL
to	NULL
DNA	NULL
sequences	NULL
containing	NULL
the	NULL
most	NULL
proximal	NULL
GHF-1	NULL
binding	NULL
site	NULL
.	NULL

Since	NULL
c-Jun	NULL
synergized	NULL
with	NULL
GHF-1	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
ascertain	NULL
whether	NULL
these	NULL
two	NULL
proteins	NULL
could	NULL
physically	NULL
interact	NULL
.	NULL

c-Jun	NULL
Binds	NULL
to	NULL
GHF-1	NULL
in	NULL
Vitro-To	NULL
directly	NULL
determine	NULL
whether	NULL
c-Jun	NULL
and	NULL
GHF-1	NULL
physically	NULL
interact	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
vitro	NULL
binding	NULL
assays	NULL
whereby	NULL
the	NULL
ability	NULL
of	NULL
either	NULL
recombinant	NULL
protein	NULL
A	NULL
alone	NULL
or	NULL
a	NULL
protein	NULL
A-GHF-1	NULL
fusion	NULL
protein	NULL
prebound	NULL
to	NULL
IgG	NULL
beads	NULL
to	NULL
pull	NULL
down	NULL
radiolabeled	NULL
c-Fos	NULL
,	NULL
c-Jun	NULL
,	NULL
or	NULL
GHF-1	NULL
proteins	NULL
was	NULL
assessed	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Twenty	NULL
percent	NULL
of	NULL
the	NULL
radiolabeled	NULL
protein	NULL
input	NULL
of	NULL
rat	NULL
c-Fos	NULL
,	NULL
human	NULL
c-Jun	NULL
,	NULL
and	NULL
rat	NULL
GHF-1	NULL
is	NULL
shown	NULL
in	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
.	NULL

Rat	NULL
c-Fos	NULL
showed	NULL
no	NULL
interaction	NULL
with	NULL
either	NULL
the	NULL
protein	NULL
A	NULL
alone	NULL
or	NULL
protein	NULL
A-GHF-1	NULL
beads	NULL
(	NULL
anes	NULL
2-3	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
c-Jun	NULL
showed	NULL
a	NULL
low	NULL
level	NULL
of	NULL
interaction	NULL
with	NULL
the	NULL
protein	NULL
A	NULL
beads	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
there	NULL
was	NULL
significant	NULL
binding	NULL
of	NULL
c-Jun	NULL
to	NULL
protein	NULL
A-GHEF-1	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

Since	NULL
GHF-1	NULL
is	NULL
known	NULL
to	NULL
homodimerize	NULL
(	NULL
36	NULL
)	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
radiolabeled	NULL
GHF-1	NULL
interacted	NULL
with	NULL
the	NULL
protein	NULL
A-GHF-1	NULL
beads	NULL
,	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
the	NULL
binding	NULL
assay	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
but	NULL
that	NULL
labeled	NULL
GHF-1	NULL
binds	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
only	NULL
minimally	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
17144	NULL
A	NULL
1__31	NULL
57	NULL
340	NULL
e-jun	NULL
wm	NULL
[	NULL
|	NULL
s	NULL
|	NULL
___	NULL
Tap	NULL
[	NULL
Tap|pep|	NULL
11111	NULL
|C	NULL
J	NULL
B¥	NULL
jun	NULL
kinase	NULL
GSK3	NULL
vwjun	NULL
on	NULL
-	NULL
[	NULL
|	NULL
TAD	NULL
[	NULL
rap|	NULL
pso	NULL
[	NULL
111	NULL
|	NULL
c	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
basal	NULL
+	NULL
c-jun	NULL
4	NULL
v-jun	NULL
0.58	NULL
12.86	NULL
w	NULL
<	NULL
4-	NULL
46	NULL
kDa	NULL
Gnd	NULL
4-	NULL
c-Jun	NULL
botton	NULL
i	NULL
4-	NULL
v-Jun	NULL
e	NULL
r	NULL
mot	NULL
duns	NULL
|	NULL
<	NULL
-	NULL
cio	NULL
;	NULL
I-	NULL
30	NULL
kDa	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
regions	NULL
of	NULL
c-Jun	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
rPRL	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
,	NULL
Jun	NULL
constructs	NULL
used	NULL
to	NULL
investigate	NULL
structure-function	NULL
relationships	NULL
.	NULL

Numbers	NULL
indicate	NULL
amino	NULL
acids	NULL
1-340	NULL
.	NULL

8	NULL
,	NULL
NH	NULL
,	NULL
-terminal	NULL
5-domain	NULL
;	NULL
TAD	NULL
,	NULL
transactivation	NULL
domain	NULL
(	NULL
s	NULL
)	NULL
;	NULL
DBD	NULL
,	NULL
DNA-binding	NULL
domain	NULL
;	NULL
LLLLL	NULL
,	NULL
leucine	NULL
zipper	NULL
domain	NULL
;	NULL
P	NULL
,	NULL
phosphorylation	NULL
site	NULL
;	NULL
GSK3	NULL
,	NULL
glycogen	NULL
synthase	NULL
kinase	NULL
3	NULL
;	NULL
X	NULL
,	NULL
point	NULL
mutation	NULL
.	NULL

B	NULL
,	NULL
the	NULL
5-domain	NULL
of	NULL
c-Jun	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
rPRL	NULL
promoter	NULL
activity	NULL
.	NULL

GH	NULL
,	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
3	NULL
pg	NULL
of	NULL
pA	NULL
,	NULL
PRLluc-425	NULL
reporter	NULL
with	NULL
20	NULL
pg	NULL
of	NULL
pRSVB-globin	NULL
,	NULL
pRSVe-jun	NULL
,	NULL
or	NULL
pRSVv-jun	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
fold	NULL
for	NULL
three	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

C	NULL
,	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
Western	NULL
blot	NULL
.	NULL

Equivalent	NULL
amounts	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
of	NULL
cell	NULL
lysate	NULL
from	NULL
transfected	NULL
GH	NULL
,	NULL
cells	NULL
were	NULL
run	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
e-Jun/AP-1	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
and	NULL
detected	NULL
using	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
30-min	NULL
exposure	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
GHF-1	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
and	NULL
detected	NULL
using	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
30-min	NULL
exposure	NULL
.	NULL

On	NULL
both	NULL
panels	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
recombinant	NULL
histidine-tagged	NULL
c-Jun	NULL
protein	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
GH	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
pRSVv-jun	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
GH	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
pRSVe-jun	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
GH	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
empty	NULL
pRSV	NULL
-globin	NULL
vector	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
wild-type	NULL
GH	NULL
,	NULL
cells	NULL
untransfected	NULL
.	NULL

Arrows	NULL
point	NULL
to	NULL
size	NULL
standards	NULL
of	NULL
46	NULL
kDa	NULL
(	NULL
ovalbumin	NULL
)	NULL
and	NULL
30	NULL
kDa	NULL
(	NULL
carbonic	NULL
anhydrase	NULL
)	NULL
.	NULL

(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
labeled	NULL
c-Fos	NULL
to	NULL
bind	NULL
to	NULL
protein	NULL
A-GHF-1	NULL
beads	NULL
indicates	NULL
that	NULL
there	NULL
is	NULL
specificity	NULL
to	NULL
the	NULL
GHF-1-c-Jun	NULL
interaction	NULL
.	NULL

DISCUSSION	NULL
Although	NULL
our	NULL
understanding	NULL
of	NULL
c-Jun	NULL
function	NULL
has	NULL
progressed	NULL
quite	NULL
rapidly	NULL
,	NULL
some	NULL
of	NULL
the	NULL
original	NULL
observations	NULL
relating	NULL
to	NULL
the	NULL
differential	NULL
and	NULL
cell-specific	NULL
effects	NULL
of	NULL
c-Jun	NULL
versus	NULL
v-Jun	NULL
in	NULL
transcription	NULL
and	NULL
transformation	NULL
assays	NULL
have	NULL
remained	NULL
unexplained	NULL
.	NULL

In	NULL
this	NULL
paper	NULL
,	NULL
we	NULL
show	NULL
that	NULL
c-Jun	NULL
inhibition	NULL
of	NULL
rPRL	NULL
promoter	NULL
basal	NULL
activity	NULL
requires	NULL
the	NULL
c-Jun	NULL
8-domain	NULL
,	NULL
the	NULL
FP	NULL
II	NULL
site	NULL
,	NULL
and	NULL
the	NULL
pituitary-specific	NULL
cell	NULL
type	NULL
.	NULL

Alteration	NULL
of	NULL
any	NULL
one	NULL
of	NULL
these	NULL
features	NULL
switches	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
Jun	NULL
to	NULL
that	NULL
of	NULL
an	NULL
activator	NULL
.	NULL

Moreover	NULL
,	NULL
since	NULL
the	NULL
putative	NULL
DNA	NULL
binding	NULL
sites	NULL
for	NULL
both	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
proteins	NULL
are	NULL
the	NULL
same	NULL
,	NULL
the	NULL
striking	NULL
differences	NULL
in	NULL
their	NULL
effects	NULL
on	NULL
the	NULL
rPRL	NULL
6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
A	NULL
180	NULL
160-2	NULL
i140	NULL
“	NULL
5	NULL
m	NULL
<	NULL
0	NULL
120-	NULL
<	NULL
émo-8	NULL
i	NULL
&	NULL
80	NULL
p	NULL
g	NULL
60-1	NULL
E	NULL
40-1	NULL
20-1	NULL
0-ao	NULL
gpo	NULL
£0	NULL
£	NULL
4	NULL
4	NULL
2	NULL
-	NULL
E	NULL
3	NULL
3	NULL
a	NULL
a	NULL
Po	NULL
f	NULL
+	NULL
E	NULL
9	NULL
O	NULL
+	NULL
+	NULL
[	NULL
1	NULL
|	NULL
as	NULL
|	NULL
zs	NULL
|	NULL
is	NULL
|	NULL
is	NULL
|	NULL
4s	NULL
|	NULL
4	NULL
c-Jun	NULL
<	NULL
4-	NULL
y-Jan	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

A	NULL
,	NULL
c-Jun	NULL
synergizes	NULL
with	NULL
the	NULL
GHF-1	NULL
transactivation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
Hela	NULL
cells	NULL
.	NULL

Exponentially	NULL
growing	NULL
Hela	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
in	NULL
triplicate	NULL
with	NULL
3	NULL
ug	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
,	NULL
pA	NULL
,	NULL
PRLluc-425	NULL
,	NULL
with	NULL
either	NULL
5	NULL
ug	NULL
of	NULL
pRSV	NULL
-globin	NULL
or	NULL
pRSVGHEF-1	NULL
and/or	NULL
with	NULL
either	NULL
20	NULL
pg	NULL
of	NULL
pRSVB-globin	NULL
or	NULL
pRSVe-jun	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
-fold	NULL
+	NULL
S.E	NULL
.	NULL

for	NULL
eight	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
for	NULL
basal	NULL
,	NULL
GHF-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
c-Jun	NULL
+	NULL
GHF-1	NULL
and	NULL
for	NULL
five	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
for	NULL
v-Jun	NULL
and	NULL
v-Jun	NULL
+	NULL
GHF-1	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
confirms	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
proteins	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
cell	NULL
lysates	NULL
from	NULL
transfected	NULL
Hela	NULL
cells	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
probed	NULL
with	NULL
e-Jun/AP-1	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
and	NULL
detected	NULL
using	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
30-min	NULL
exposure	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
actin	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
,	NULL
clone	NULL
C4	NULL
,	NULL
and	NULL
detected	NULL
with	NULL
Amersham	NULL
ECL	NULL
with	NULL
a	NULL
3-s	NULL
exposure	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
Hela	NULL
cells	NULL
transfected	NULL
with	NULL
reporter	NULL
construct	NULL
and	NULL
control	NULL
DNA	NULL
only	NULL
;	NULL
Zane	NULL
2	NULL
,	NULL
co-transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
pRSVGHEF-1	NULL
;	NULL
Zane	NULL
3	NULL
,	NULL
co-transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pRSVe-jun	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
co-transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pRSVc-jun	NULL
and	NULL
5	NULL
pug	NULL
pRSVGHEF-1	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
co-transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pRSVv-Jjun	NULL
;	NULL
Zane	NULL
6	NULL
,	NULL
co-transfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pRSVv-jun	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pRSVGHEF-1	NULL
.	NULL

promoter	NULL
strongly	NULL
suggest	NULL
that	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
mediate	NULL
their	NULL
differential	NULL
effects	NULL
upon	NULL
the	NULL
same	NULL
promoter	NULL
in	NULL
the	NULL
same	NULL
cell	NULL
type	NULL
due	NULL
to	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
DNA	NULL
binding	NULL
speci-ficities	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
the	NULL
model	NULL
that	NULL
the	NULL
structural	NULL
difference	NULL
between	NULL
these	NULL
two	NULL
Jun	NULL
isoforms	NULL
,	NULL
specifically	NULL
the	NULL
5-domain	NULL
,	NULL
dictates	NULL
a	NULL
second	NULL
level	NULL
of	NULL
transcription	NULL
control	NULL
by	NULL
governing	NULL
factor-factor	NULL
interactions	NULL
.	NULL

The	NULL
information	NULL
gained	NULL
provides	NULL
critical	NULL
mechanistic	NULL
insights	NULL
into	NULL
the	NULL
molecular	NULL
code	NULL
by	NULL
which	NULL
Jun	NULL
proteins	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
the	NULL
8-domain	NULL
in	NULL
v-Jun	NULL
renders	NULL
this	NULL
protein	NULL
unable	NULL
to	NULL
bind	NULL
or	NULL
to	NULL
be	NULL
phosphorylated	NULL
by	NULL
Jun	NULL
kinases	NULL
(	NULL
JNKs	NULL
)	NULL
,	NULL
yet	NULL
v-Jun	NULL
is	NULL
typically	NULL
a	NULL
much	NULL
more	NULL
potent	NULL
oncogene	NULL
,	NULL
raising	NULL
the	NULL
interesting	NULL
possibility	NULL
that	NULL
phosphorylation	NULL
is	NULL
required	NULL
primarily	NULL
to	NULL
``	NULL
inactivate	NULL
``	NULL
the	NULL
8-domain	NULL
in	NULL
c-Jun	NULL
(	NULL
25	NULL
,	NULL
55	NULL
)	NULL
.	NULL

From	NULL
these	NULL
data	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
catalytically	NULL
inactive	NULL
JNK	NULL
,	NULL
which	NULL
binds	NULL
tightly	NULL
to	NULL
the	NULL
&	NULL
-domain	NULL
,	NULL
functions	NULL
as	NULL
the	NULL
putative	NULL
repressor	NULL
,	NULL
possibly	NULL
by	NULL
masking	NULL
the	NULL
amino-terminal	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
Relative	NULL
Promoter	NULL
Activity	NULL
-425	NULL
AL	NULL
A2	NULL
AL,3	NULL
+	NULL
pRSVc-jun	NULL
Fig	NULL
.	NULL

6.	NULL
c-Jun	NULL
Activation	NULL
of	NULL
rPRL	NULL
in	NULL
HeLa	NULL
cells	NULL
maps	NULL
to	NULL
footprint	NULL
I	NULL
.	NULL

The	NULL
indicated	NULL
rPRL	NULL
site-specific	NULL
mutants	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
with	NULL
either	NULL
20	NULL
ug	NULL
of	NULL
pRSV	NULL
B-globin	NULL
or	NULL
pRSVe-jun	NULL
.	NULL

-Fold	NULL
activation	NULL
was	NULL
determined	NULL
relative	NULL
to	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
each	NULL
individual	NULL
promoter	NULL
construct	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
-fold	NULL
+	NULL
S.E	NULL
.	NULL

for	NULL
two	NULL
transfections	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
S	NULL
a*	NULL
<	NULL
-	NULL
c-Fos	NULL
4-	NULL
c-Jun	NULL
®	NULL
s=	NULL
URB	NULL
<	NULL
-CGHE-1	NULL
Fic	NULL
.	NULL

7.	NULL
c-Jun	NULL
Binds	NULL
to	NULL
GHF-1	NULL
in	NULL
vitro	NULL
.	NULL

Radiolabeled	NULL
c-Jun	NULL
,	NULL
made	NULL
by	NULL
translating	NULL
c-jun	NULL
RNA	NULL
in	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
supplemented	NULL
with	NULL
[	NULL
*°SJmethionine	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
agarose	NULL
beads	NULL
containing	NULL
either	NULL
protein	NULL
A	NULL
or	NULL
a	NULL
protein	NULL
A-GHF-1	NULL
fusion	NULL
.	NULL

Rat	NULL
c-Fos	NULL
and	NULL
rat	NULL
GHF-1	NULL
recombinant	NULL
proteins	NULL
were	NULL
radiolabeled	NULL
and	NULL
incubated	NULL
with	NULL
protein	NULL
A	NULL
or	NULL
protein	NULL
A-GHF-1	NULL
beads	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

This	NULL
figure	NULL
shows	NULL
a	NULL
4-day	NULL
exposure	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
20	NULL
%	NULL
of	NULL
radiolabeled	NULL
rat	NULL
c-Fos	NULL
input	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
rat	NULL
c-Fos	NULL
bound	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
rat	NULL
c-Fos	NULL
bound	NULL
to	NULL
protein	NULL
A-GHPF-1	NULL
beads	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
20	NULL
%	NULL
of	NULL
radiolabeled	NULL
human	NULL
c-Jun	NULL
input	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
human	NULL
c-Jun	NULL
bound	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
;	NULL
Zane	NULL
6	NULL
,	NULL
human	NULL
c-Jun	NULL
bound	NULL
to	NULL
protein	NULL
A-GHEF-1	NULL
beads	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
20	NULL
%	NULL
of	NULL
radiolabeled	NULL
rat	NULL
GHPF-1	NULL
input	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
rat	NULL
GHF-1	NULL
bound	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
;	NULL
Zane	NULL
9	NULL
,	NULL
rat	NULL
GHF-1	NULL
bound	NULL
to	NULL
protein	NULL
A-GHF-1	NULL
beads	NULL
.	NULL

transactivation	NULL
domain	NULL
and/or	NULL
influencing	NULL
c-Jun	NULL
's	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
,	NULL
and	NULL
that	NULL
JNK	NULL
activation	NULL
causes	NULL
its	NULL
release	NULL
from	NULL
c-Jun	NULL
(	NULL
18	NULL
,	NULL
24-26	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
argue	NULL
against	NULL
this	NULL
hypothesis	NULL
:	NULL
1	NULL
)	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
only	NULL
a	NULL
small	NULL
fraction	NULL
(	NULL
5-10	NULL
%	NULL
)	NULL
of	NULL
c-Jun	NULL
in	NULL
quiescent	NULL
cells	NULL
is	NULL
bound	NULL
with	NULL
JNK	NULL
(	NULL
25	NULL
)	NULL
;	NULL
2	NULL
)	NULL
the	NULL
region	NULL
of	NULL
the	NULL
8-domain	NULL
required	NULL
for	NULL
JNK	NULL
binding	NULL
(	NULL
amino-terminal	NULL
)	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
required	NULL
for	NULL
repression	NULL
(	NULL
carboxyl-terminal	NULL
)	NULL
(	NULL
18	NULL
,	NULL
23	NULL
,	NULL
25	NULL
)	NULL
;	NULL
3	NULL
)	NULL
the	NULL
JNK	NULL
pathway	NULL
is	NULL
primarily	NULL
an	NULL
apoptotic	NULL
one	NULL
and	NULL
not	NULL
a	NULL
transforming	NULL
one	NULL
(	NULL
56	NULL
)	NULL
;	NULL
and	NULL
4	NULL
)	NULL
the	NULL
difference	NULL
in	NULL
c-Jun	NULL
versus	NULL
v-Jun	NULL
protein	NULL
levels	NULL
is	NULL
small	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
8-domain-dependent	NULL
mecha-nisms	NULL
,	NULL
other	NULL
than	NULL
JNK	NULL
binding	NULL
or	NULL
ubiquitination	NULL
control	NULL
,	NULL
must	NULL
exist	NULL
and	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
elucidated	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
cellular	NULL
promoter	NULL
in	NULL
a	NULL
homologous	NULL
and	NULL
highly	NULL
specialized	NULL
neuroendocrine	NULL
cell	NULL
line	NULL
rather	NULL
than	NULL
a	NULL
viral	NULL
or	NULL
artificial	NULL
heterologous	NULL
promoter	NULL
in	NULL
a	NULL
fibroblast	NULL
cell	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
8-domain	NULL
maintains	NULL
cell-specific	NULL
effects	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
c-Jun	NULL
8-domain	NULL
in	NULL
our	NULL
system	NULL
was	NULL
to	NULL
inhibit	NULL
rPRL	NULL
promoter	NULL
activity	NULL
rather	NULL
than	NULL
to	NULL
mediate	NULL
a	NULL
partial	NULL
activation	NULL
or	NULL
simply	NULL
produce	NULL
no	NULL
effect	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
9	NULL
,	NULL
21	NULL
)	NULL
.	NULL

If	NULL
c-Jun	NULL
were	NULL
to	NULL
bind	NULL
a	NULL
putative	NULL
pituitary-specific	NULL
repressor	NULL
via	NULL
the	NULL
8-domain	NULL
and	NULL
thus	NULL
recruit	NULL
this	NULL
repressor	NULL
to	NULL
an	NULL
AP-1	NULL
site	NULL
by	NULL
c-Jun	NULL
binding	NULL
to	NULL
DNA	NULL
,	NULL
then	NULL
c-Jun	NULL
should	NULL
function	NULL
as	NULL
an	NULL
intrinsic	NULL
inhibitor	NULL
on	NULL
all	NULL
AP-1-containing	NULL
promoters	NULL
in	NULL
the	NULL
GH	NULL
,	NULL
cell	NULL
type	NULL
.	NULL

However	NULL
,	NULL
our	NULL
current	NULL
and	NULL
published	NULL
data	NULL
show	NULL
that	NULL
c-Jun	NULL
activates	NULL
the	NULL
AP-1-containing	NULL
Fos	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
collagenase	NULL
promoters	NULL
(	NULL
40	NULL
)	NULL
in	NULL
these	NULL
GH	NULL
,	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
rPRL	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
a	NULL
canonical	NULL
AP-1	NULL
site	NULL
(	NULL
41	NULL
)	NULL
.	NULL

With	NULL
regard	NULL
to	NULL
mechanism	NULL
,	NULL
if	NULL
c-Jun	NULL
were	NULL
to	NULL
titrate	NULL
a	NULL
putative	NULL
cell-specific	NULL
co-activator	NULL
,	NULL
then	NULL
this	NULL
co-activator	NULL
would	NULL
have	NULL
to	NULL
display	NULL
specificity	NULL
for	NULL
the	NULL
rPRL	NULL
17145	NULL
co-repressor	NULL
co-activator	NULL
FPIV	NULL
_	NULL
FP	NULL
IMI	NULL
FP	NULL
II	NULL
BTE	NULL
FPI	NULL
-125	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
for	NULL
c-Jun	NULL
repression	NULL
of	NULL
rPRL	NULL
promoter	NULL
activity	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
.	NULL

c-Jun	NULL
stabilizes	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
pituitary	NULL
cell-specific	NULL
repressor	NULL
protein	NULL
to	NULL
FP	NULL
II	NULL
by	NULL
a	NULL
protein-protein	NULL
interaction	NULL
mechanism	NULL
that	NULL
requires	NULL
the	NULL
8-domain	NULL
of	NULL
c-Jun	NULL
.	NULL

Thus	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
8-domain	NULL
,	NULL
elimination	NULL
of	NULL
the	NULL
pituitary-specific	NULL
inhibitor	NULL
,	NULL
or	NULL
site-specific	NULL
mutation	NULL
of	NULL
FP	NULL
II	NULL
would	NULL
nullify	NULL
this	NULL
inhibitory	NULL
effect	NULL
.	NULL

In	NULL
HeLa	NULL
nonpituitary	NULL
cells	NULL
devoid	NULL
of	NULL
the	NULL
pituitary-specific	NULL
repressor	NULL
,	NULL
c-Jun	NULL
functionally	NULL
interacts	NULL
with	NULL
GHEF-1	NULL
to	NULL
cooperatively	NULL
activate	NULL
the	NULL
rPRL	NULL
promoter	NULL
via	NULL
FP	NULL
I.	NULL
c-Jun	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
white	NULL
ovals	NULL
,	NULL
the	NULL
pituitary	NULL
cell-specific	NULL
repressor	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
black	NULL
squares	NULL
,	NULL
and	NULL
GHF-1	NULL
is	NULL
represented	NULL
by	NULL
the	NULL
gray	NULL
rectangle	NULL
.	NULL

and	NULL
rGH	NULL
genes	NULL
,	NULL
since	NULL
c-Jun	NULL
inhibits	NULL
both	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
v-Jun	NULL
activates	NULL
both	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
we	NULL
initially	NULL
surmised	NULL
that	NULL
c-Jun	NULL
might	NULL
be	NULL
interfering	NULL
with	NULL
the	NULL
function	NULL
of	NULL
Pit-1/GHF-1	NULL
by	NULL
binding	NULL
to	NULL
this	NULL
factor	NULL
,	NULL
thereby	NULL
inhibiting	NULL
both	NULL
rPRL	NULL
and	NULL
rGH	NULL
promoter	NULL
activ-ities	NULL
.	NULL

Surprisingly	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
c-Jun	NULL
does	NULL
interact	NULL
with	NULL
Pit-1/GHEF-1	NULL
directly	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
but	NULL
that	NULL
such	NULL
an	NULL
interaction	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
in	NULL
a	NULL
Hela	NULL
cell	NULL
reconstitution	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
via	NULL
the	NULL
most	NULL
proximal	NULL
Pit-1/GHF-1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
mapping	NULL
of	NULL
the	NULL
cis-acting	NULL
element	NULL
mediating	NULL
c-Jun	NULL
's	NULL
inhibitory	NULL
response	NULL
co-localized	NULL
the	NULL
Jun	NULL
responsive	NULL
element	NULL
to	NULL
the	NULL
FP	NULL
II	NULL
site	NULL
,	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
putative	NULL
repressor	NULL
,	NULL
F2F	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Since	NULL
F2F	NULL
(	NULL
43	NULL
)	NULL
and	NULL
the	NULL
c-Jun	NULL
inhibitor	NULL
both	NULL
require	NULL
an	NULL
intact	NULL
FP	NULL
II	NULL
site	NULL
,	NULL
the	NULL
formal	NULL
possibility	NULL
remains	NULL
that	NULL
these	NULL
two	NULL
proteins	NULL
might	NULL
belong	NULL
to	NULL
the	NULL
same	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Nevertheless	NULL
,	NULL
it	NULL
is	NULL
highly	NULL
unlikely	NULL
that	NULL
they	NULL
will	NULL
be	NULL
the	NULL
same	NULL
factor	NULL
.	NULL

Indeed	NULL
,	NULL
there	NULL
are	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
that	NULL
show	NULL
that	NULL
the	NULL
F2F	NULL
repressor	NULL
functions	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
nonpituitary	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
Hela	NULL
and	NULL
Rat	NULL
2	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
putative	NULL
target	NULL
of	NULL
c-Jun	NULL
functions	NULL
in	NULL
a	NULL
GH	NULL
,	NULL
pitui-tary-	NULL
and	NULL
FP	NULL
II-specific	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
the	NULL
apparent	NULL
absence	NULL
of	NULL
the	NULL
c-Jun	NULL
inhibitor	NULL
in	NULL
Hela	NULL
nonpituitary	NULL
cells	NULL
that	NULL
allows	NULL
c-Jun	NULL
to	NULL
switch	NULL
function	NULL
and	NULL
become	NULL
an	NULL
activator	NULL
of	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

These	NULL
data	NULL
imply	NULL
that	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
c-Jun	NULL
8-domain	NULL
and	NULL
the	NULL
pituitary-specific	NULL
inhibitor	NULL
is	NULL
dominant	NULL
,	NULL
and	NULL
abrogation	NULL
of	NULL
this	NULL
interaction	NULL
is	NULL
required	NULL
in	NULL
GH	NULL
,	NULL
pituitary	NULL
cells	NULL
in	NULL
order	NULL
to	NULL
unmask	NULL
the	NULL
recessive	NULL
and	NULL
activating	NULL
effects	NULL
of	NULL
c-Jun	NULL
,	NULL
which	NULL
are	NULL
mediated	NULL
by	NULL
FP	NULL
I	NULL
and	NULL
GHF-1	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
,	NULL
we	NULL
have	NULL
formulated	NULL
a	NULL
model	NULL
,	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
which	NULL
incorporates	NULL
all	NULL
of	NULL
these	NULL
features	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
c-Jun	NULL
stabilizes	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
pituitary	NULL
cell-specific	NULL
repressor	NULL
protein	NULL
to	NULL
FP	NULL
II	NULL
,	NULL
by	NULL
a	NULL
protein-protein	NULL
interaction	NULL
mechanism	NULL
that	NULL
would	NULL
require	NULL
the	NULL
8-domain	NULL
of	NULL
c-Jun	NULL
.	NULL

Thus	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
8-domain	NULL
,	NULL
elimination	NULL
of	NULL
the	NULL
pituitary-specific	NULL
inhibitor	NULL
,	NULL
or	NULL
site-specific	NULL
mutation	NULL
of	NULL
FP	NULL
II	NULL
,	NULL
would	NULL
nullify	NULL
this	NULL
dominant	NULL
inhibitory	NULL
effect	NULL
and	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
17146	NULL
unmask	NULL
the	NULL
recessive	NULL
activating	NULL
effect	NULL
of	NULL
the	NULL
GHF-1°c-Jun	NULL
complex	NULL
acting	NULL
via	NULL
FP	NULL
I	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
model	NULL
is	NULL
the	NULL
observation	NULL
that	NULL
both	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
functionally	NULL
interact	NULL
with	NULL
GHF-1	NULL
to	NULL
cooperatively	NULL
activate	NULL
the	NULL
rPRL	NULL
promoter	NULL
via	NULL
FP	NULL
I	NULL
(	NULL
Figs	NULL
.	NULL

5A	NULL
and	NULL
6	NULL
)	NULL
in	NULL
HeLa	NULL
nonpituitary	NULL
cells	NULL
devoid	NULL
of	NULL
the	NULL
pituitary-specific	NULL
repressor	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
region	NULL
distinct	NULL
from	NULL
the	NULL
8-domain	NULL
of	NULL
c-Jun	NULL
interacts	NULL
with	NULL
GHF-1	NULL
,	NULL
since	NULL
both	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
synergize	NULL
with	NULL
GHF-1	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
8-domain	NULL
does	NULL
appear	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
GHF-interaction	NULL
,	NULL
since	NULL
c-Jun	NULL
cooperates	NULL
more	NULL
efficiently	NULL
with	NULL
GHF-1	NULL
than	NULL
does	NULL
v-Jun	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
if	NULL
c-Jun	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
GHF-1	NULL
to	NULL
stimulate	NULL
rPRL	NULL
promoter	NULL
activity	NULL
,	NULL
why	NULL
is	NULL
this	NULL
interaction	NULL
recessive	NULL
to	NULL
the	NULL
c-Jun-pituitary-specific	NULL
F2F	NULL
interaction	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
?	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
FP	NULL
II	NULL
sequence	NULL
functions	NULL
as	NULL
an	NULL
inhibitory	NULL
element	NULL
only	NULL
when	NULL
juxtaposed	NULL
to	NULL
the	NULL
vicinal	NULL
BTE	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
site-specific	NULL
mutation	NULL
of	NULL
the	NULL
BTE	NULL
renders	NULL
the	NULL
rPRL	NULL
promoter	NULL
devoid	NULL
of	NULL
basal	NULL
activity	NULL
,	NULL
despite	NULL
intact	NULL
GHF-1	NULL
binding	NULL
sites	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
c-Jun	NULL
enhances	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
FP	NULL
II	NULL
site	NULL
and	NULL
if	NULL
this	NULL
effect	NULL
is	NULL
transduced	NULL
to	NULL
the	NULL
BTE	NULL
,	NULL
as	NULL
shown	NULL
previously	NULL
,	NULL
then	NULL
the	NULL
functional	NULL
interaction	NULL
between	NULL
c-Jun	NULL
and	NULL
the	NULL
pituitary-specific	NULL
FP	NULL
II-binding	NULL
factor	NULL
should	NULL
dominate	NULL
over	NULL
the	NULL
c-JunmGHF-1	NULL
response	NULL
.	NULL

Finally	NULL
,	NULL
implicit	NULL
in	NULL
this	NULL
model	NULL
is	NULL
that	NULL
DNA	NULL
binding	NULL
of	NULL
either	NULL
c-Jun	NULL
or	NULL
v-Jun	NULL
to	NULL
the	NULL
rPRL	NULL
promoter	NULL
is	NULL
not	NULL
necessary	NULL
,	NULL
but	NULL
instead	NULL
c-Jun	NULL
and	NULL
v-Jun	NULL
would	NULL
mediate	NULL
their	NULL
effects	NULL
through	NULL
protein-protein	NULL
interactions	NULL
with	NULL
other	NULL
factors	NULL
whose	NULL
presence	NULL
is	NULL
dictated	NULL
by	NULL
the	NULL
developmental	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

This	NULL
notion	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
canonical	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
rPRL	NULL
promoter	NULL
.	NULL

Although	NULL
the	NULL
8-domain	NULL
definitely	NULL
affects	NULL
c-Jun	NULL
activity	NULL
,	NULL
the	NULL
cumulated	NULL
data	NULL
indicate	NULL
that	NULL
its	NULL
function	NULL
is	NULL
much	NULL
more	NULL
complicated	NULL
than	NULL
a	NULL
simple	NULL
interaction	NULL
of	NULL
the	NULL
8-domain	NULL
with	NULL
a	NULL
putative	NULL
cell-specific	NULL
repressor	NULL
,	NULL
as	NULL
initially	NULL
postulated	NULL
(	NULL
9	NULL
,	NULL
23	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
c-Jun	NULL
to	NULL
induce	NULL
differentiation	NULL
in	NULL
F9	NULL
teratocarcinoma	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
and	NULL
to	NULL
inhibit	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
highly	NULL
specialized	NULL
promoters	NULL
(	NULL
30-32	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
putative	NULL
effects	NULL
of	NULL
the	NULL
8-domain	NULL
may	NULL
be	NULL
governed	NULL
by	NULL
multiple	NULL
regulatory	NULL
influences	NULL
,	NULL
including	NULL
the	NULL
differentiated	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
environmental	NULL
cues	NULL
,	NULL
signaling	NULL
events	NULL
,	NULL
repressors	NULL
,	NULL
co-activators	NULL
,	NULL
and	NULL
ubiquitination	NULL
machinery	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
if	NULL
to	NULL
verify	NULL
this	NULL
point	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
c-Jun	NULL
amino-terminal	NULL
transactivation	NULL
domain	NULL
,	NULL
including	NULL
the	NULL
8-domain	NULL
,	NULL
functionally	NULL
(	NULL
and	NULL
in	NULL
some	NULL
cases	NULL
physically	NULL
)	NULL
interacts	NULL
with	NULL
1	NULL
)	NULL
certain	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
MyoD	NULL
,	NULL
myogenin	NULL
,	NULL
steroid	NULL
receptors	NULL
,	NULL
and	NULL
STAT3B	NULL
,	NULL
to	NULL
either	NULL
repress	NULL
or	NULL
activate	NULL
transcription	NULL
of	NULL
specific	NULL
target	NULL
genes	NULL
,	NULL
and	NULL
2	NULL
)	NULL
JNK	NULL
(	NULL
18	NULL
,	NULL
24	NULL
,	NULL
29-32	NULL
,	NULL
57	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
8-domain	NULL
may	NULL
contain	NULL
several	NULL
functional	NULL
faces	NULL
,	NULL
one	NULL
interacting	NULL
with	NULL
JNK	NULL
and	NULL
a	NULL
separate	NULL
face	NULL
that	NULL
might	NULL
interact	NULL
with	NULL
other	NULL
proteins	NULL
,	NULL
some	NULL
of	NULL
which	NULL
may	NULL
be	NULL
cell-specific	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
James	NULL
Oberwetter	NULL
,	NULL
Steven	NULL
Deitz	NULL
,	NULL
Linda	NULL
Alexander	NULL
,	NULL
and	NULL
Sudha	NULL
Rajnarayan	NULL
for	NULL
preliminary	NULL
experiments	NULL
,	NULL
Jeanette	NULL
Wagner	NULL
and	NULL
Kelley	NULL
Fantle	NULL
for	NULL
technical	NULL
assistance	NULL
,	NULL
Michael	NULL
Karin	NULL
for	NULL
the	NULL
c-Jun	NULL
and	NULL
GHF-1	NULL
expression	NULL
vectors	NULL
,	NULL
and	NULL
members	NULL
of	NULL
the	NULL
Gutierrez-Hartmann	NULL
laboratory	NULL
for	NULL
their	NULL
helpful	NULL
suggestions	NULL
and	NULL
com-ments	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Andrew	NULL
Bradford	NULL
,	NULL
John	NULL
Tentler	NULL
,	NULL
David	NULL
Gordon	NULL
,	NULL
and	NULL
Lynn	NULL
Heasley	NULL
for	NULL
critical	NULL
reading	NULL
and	NULL
discussions	NULL
of	NULL
this	NULL
manu-script	NULL
.	NULL

Tissue	NULL
culture	NULL
media	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
Tissue	NULL
Culture	NULL
Core	NULL
Facility	NULL
of	NULL
the	NULL
Colorado	NULL
Cancer	NULL
Center	NULL
.	NULL

REFERENCES	NULL
.	NULL

Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Smeal	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17	NULL
,	NULL
418-422	NULL
2	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Sigler	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
246	NULL
,	NULL
911-916	NULL
3	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
882	NULL
,	NULL
166-171	NULL
4	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
1386-1392	NULL
5	NULL
.	NULL

Maki	NULL
,	NULL
Y.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
C.	NULL
,	NULL
Starbuck	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
2848-2852	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
375-387	NULL
.	NULL

Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
917-924	NULL
a	NULL
-o	NULL
8	NULL
.	NULL

9	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

6-Domain-dependent	NULL
Switching	NULL
of	NULL
c-Jun	NULL
Activity	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
2091-2100	NULL
Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
815-825	NULL
Lee	NULL
,	NULL
W.	NULL
,	NULL
Mitchell	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
741-752	NULL
Yamaguchi-Iwai	NULL
,	NULL
Y.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Murakami	NULL
,	NULL
Y.	NULL
,	NULL
Sakai	NULL
,	NULL
M.	NULL
,	NULL
Muramatsu	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
8670-8674	NULL
Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
851	NULL
,	NULL
122-127	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
Imbra	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Jonat	NULL
,	NULL
C.	NULL
,	NULL
Herrlich	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
729-739	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Meek	NULL
,	NULL
J.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
54	NULL
,	NULL
541-552	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Mercola	NULL
,	NULL
D.	NULL
,	NULL
Grover-Bardwick	NULL
,	NULL
A.	NULL
,	NULL
Heidecker	NULL
,	NULL
G.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3507-3513	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Mercola	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Birrer	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
354	NULL
,	NULL
494-496	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

6	NULL
,	NULL
2581-2590	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Minden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2135-	NULL
2148	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Bohmann	NULL
,	NULL
D.	NULL
,	NULL
Tsuchie	NULL
,	NULL
H.	NULL
,	NULL
Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
52	NULL
,	NULL
705-712	NULL
Alani	NULL
,	NULL
V.	NULL
,	NULL
Brown	NULL
,	NULL
P.	NULL
,	NULL
Binetruy	NULL
,	NULL
B.	NULL
,	NULL
Dosaka	NULL
,	NULL
H.	NULL
,	NULL
Rosenberg	NULL
,	NULL
R.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Birrer	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
6276-6285	NULL
Bohmann	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
709-717	NULL
Bos	NULL
,	NULL
T.	NULL
,	NULL
Monteclaro	NULL
,	NULL
F.	NULL
,	NULL
Mitsunobu	NULL
,	NULL
F.	NULL
,	NULL
Jr.	NULL
,	NULL
Ball	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Vogt	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1677-1687	NULL
Havarstein	NULL
,	NULL
L.	NULL
,	NULL
Morgan	NULL
,	NULL
I.	NULL
,	NULL
Wong	NULL
,	NULL
W.-Y	NULL
.	NULL

,	NULL
and	NULL
Vogt	NULL
,	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
618-622	NULL
Derijard	NULL
,	NULL
B.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Wu	NULL
,	NULL
L-H.	NULL
,	NULL
Barrett	NULL
,	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
B.	NULL
,	NULL
Deng	NULL
,	NULL
T.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Davis	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
1025-1037	NULL
Dai	NULL
,	NULL
T.	NULL
,	NULL
Rubie	NULL
,	NULL
E.	NULL
,	NULL
Franklin	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Kraft	NULL
,	NULL
A.	NULL
,	NULL
Gillespie	NULL
,	NULL
D.	NULL
A.	NULL
F.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Oncogene	NULL
10	NULL
,	NULL
849-855	NULL
Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Banerjee	NULL
,	NULL
P.	NULL
,	NULL
Nikolakaki	NULL
,	NULL
E.	NULL
,	NULL
Dai	NULL
,	NULL
T.	NULL
,	NULL
Rubie	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Ahmad	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Avruch	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Woodgett	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
869	NULL
,	NULL
156-160	NULL
Lucibello	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Lowag	NULL
,	NULL
C.	NULL
,	NULL
Neuberg	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Muller	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
999-1007	NULL
Schule	NULL
,	NULL
R.	NULL
,	NULL
Umesono	NULL
,	NULL
K.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Bolado	NULL
,	NULL
J.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
497-504	NULL
Yang-Yen	NULL
,	NULL
H.	NULL
,	NULL
Chambard	NULL
,	NULL
J.	NULL
,	NULL
Sun	NULL
,	NULL
Y.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Schmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Drouin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1205-1215	NULL
Li	NULL
,	NULL
L.	NULL
,	NULL
Chambard	NULL
,	NULL
J.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Olson	NULL
,	NULL
E.	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
676-689	NULL
McBride	NULL
,	NULL
K.	NULL
,	NULL
Robitaille	NULL
,	NULL
L.	NULL
,	NULL
Tremblay	NULL
,	NULL
S.	NULL
,	NULL
Argentin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nemer	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
600-612	NULL
Bois-Joyeux	NULL
,	NULL
B.	NULL
,	NULL
Denissenko	NULL
,	NULL
M.	NULL
,	NULL
Thomassin	NULL
,	NULL
H.	NULL
,	NULL
Guesdon	NULL
,	NULL
S.	NULL
,	NULL
Ikonomova	NULL
,	NULL
R.	NULL
,	NULL
Bernuau	NULL
,	NULL
D.	NULL
,	NULL
Feldmann	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Danan	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
10204-10211	NULL
Elsholtz	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Semin	NULL
.	NULL

Reprod	NULL
.	NULL

Endocrinol	NULL
.	NULL

10	NULL
,	NULL
183-195	NULL
Tashjian	NULL
,	NULL
A.	NULL
H.	NULL
J.	NULL
,	NULL
Yasumura	NULL
,	NULL
Y.	NULL
,	NULL
Levine	NULL
,	NULL
L.	NULL
,	NULL
Sato	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1968	NULL
)	NULL
Endocrinology	NULL
82	NULL
,	NULL
342-352	NULL
Bodner	NULL
,	NULL
M.	NULL
,	NULL
Castrillo	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Theill	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Deerinck	NULL
,	NULL
T.	NULL
,	NULL
Ellisman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
505-518	NULL
Ingraham	NULL
,	NULL
H.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Mangalam	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Elsholtz	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
Flynn	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Lin	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Swanson	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
519-529	NULL
Keech	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

8	NULL
,	NULL
832-839	NULL
Keech	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

78	NULL
,	NULL
55-60	NULL
Keech	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Jackson	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Siddiqui	NULL
,	NULL
8	NULL
.	NULL

K.	NULL
,	NULL
Ocran	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

6	NULL
,	NULL
2059-2070	NULL
Conrad	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
Oberwetter	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Vaillancourt	NULL
,	NULL
R.	NULL
,	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
and	NULL
Guti-errez-	NULL
Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1553-1565	NULL
Oberwetter	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Conrad	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

4	NULL
,	NULL
915-923	NULL
Conrad	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
1279-1286	NULL
Jackson	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Keech	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Williamson	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2708-2719	NULL
Iverson	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Day	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
d'Emden	NULL
,	NULL
M.	NULL
,	NULL
Day	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
and	NULL
Maurer	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

4	NULL
,	NULL
1564-1571	NULL
Rajnarayan	NULL
,	NULL
S.	NULL
,	NULL
Chiono	NULL
,	NULL
M.	NULL
,	NULL
Alexander	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Gutierrez-Hartmann	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

9	NULL
,	NULL
502-512	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Hattori	NULL
,	NULL
K.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
875-885	NULL
Theill	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Castrillo	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Wu	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
842	NULL
,	NULL
945-948	NULL
Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
,	NULL
Park	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
165-168	NULL
d'Emden	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Okimura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Maurer	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

6	NULL
,	NULL
581-588	NULL
Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
.	NULL

Nilsson	NULL
,	NULL
B.	NULL
,	NULL
Abrahmsen	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Uhlen	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

4	NULL
,	NULL
1075-1080	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Herr	NULL
,	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
6958-6962	NULL
.	NULL

Gutierrez-Hartmann	NULL
,	NULL
A.	NULL
,	NULL
Siddiqui	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Loukin	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
5211-5215	NULL
Adler	NULL
,	NULL
V.	NULL
,	NULL
Polotskaya	NULL
,	NULL
A.	NULL
,	NULL
Wagner	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Kraft	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
17001-17005	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
415-424	NULL
Lange-Carter	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Pleiman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Gardner	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Blumer	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
260	NULL
,	NULL
315-319	NULL
Schaeffer	NULL
,	NULL
T.	NULL
,	NULL
Sanders	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
9097-9101	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
The	NULL
c-Jun	NULL
Inhibits	NULL
Neuroendocrine	NULL
Promoter	NULL
Activity	NULL
in	NULL
a	NULL
DNA	NULL
Sequence-and	NULL
Pituitary-specific	NULL
Manner	NULL
Kathryn	NULL
N.	NULL
Farrow	NULL
,	NULL
Nicole	NULL
Manning	NULL
,	NULL
Fred	NULL
Schaufele	NULL
and	NULL
Arthur	NULL
Gutierrez-Hartmann	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:17139-17146.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.29.17139	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
7139	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
56	NULL
references	NULL
,	NULL
19	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
7139.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

